NAME,SMILES,TARGET_NAME,TARGET_CLASS,ACCESSION,GENE,SWISSPROT,ACT_VALUE,ACT_TYPE,TDL
(S)-nitrendipine,CCOC(=O)C1=C(C)NC(C)=C([C@@H]1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,8.4,IC50,Tclin
abaloparatide,CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(N)=O,Parathyroid hormone/parathyroid hormone-related peptide receptor,GPCR,Q03431,PTH1R,PTH1R_HUMAN,9.699999809,IC50,Tclin
abarelix,CC(C)C[C@H](NC(=O)[C@@H](CC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,9.49,Ki,Tclin
abiraterone acetate,CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC=C4C4=CC=CN=C4)[C@@H]3CC=C2C1,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,8.54,IC50,Tclin
acalabrutinib,CC#CC(=O)N1CCC[C@H]1C1=NC(=C2N1C=CN=C2N)C1=CC=C(C=C1)C(=O)NC1=CC=CC=N1,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,8.29243,IC50,Tclin
acetazolamide,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.48,Ki,Tclin
acetazolamide,CC(=O)NC1=NN=C(S1)S(N)(=O)=O,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7.96,Ki,Tclin
acetylcholine,CC(=O)OCC[N+](C)(C)C,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.66,EC50,Tclin
aclidinium bromide,OC(C(=O)O[C@H]1C[N+]2(CCCOC3=CC=CC=C3)CCC1CC2)(C1=CC=CS1)C1=CC=CS1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,10.15,Ki,Tclin
adapalene,COC1=CC=C(C=C1C12CC3CC(CC(C3)C1)C2)C1=CC=C2C=C(C=CC2=C1)C(O)=O,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,7.47,Ki,Tclin
adenosine phosphate,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7,IC50,Tclin
afamelanotide,CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(N)=O,Melanocyte-stimulating hormone receptor,GPCR,Q01726,MC1R,MSHR_HUMAN,10,IC50,Tclin
afatinib,CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,6.01,Kd,Tchem
afatinib,CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,6.33,Kd,Tchem
afatinib,CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,8.3,Kd,Tclin
afatinib,CN(C)C\C=C\C(=O)NC1=CC2=C(C=C1O[C@H]1CCOC1)N=CN=C2NC1=CC(Cl)=C(F)C=C1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.64,Kd,Tclin
alectinib,CCC1=CC2=C(C=C1N1CCC(CC1)N1CCOCC1)C(C)(C)C1=C(C3=CC=C(C=C3N1)C#N)C2=O,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.318758965,IC50,Tclin
aliskiren,COCCCOC1=C(OC)C=CC(C[C@@H](C[C@H](N)[C@@H](O)C[C@@H](C(C)C)C(=O)NCC(C)(C)C(N)=O)C(C)C)=C1,Renin,Enzyme,P00797,REN,RENI_HUMAN,9.22,IC50,Tclin
alitretinoin,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,6.52,EC50,Tclin
alitretinoin,C\C(\C=C\C1=C(C)CCCC1(C)C)=C\C=C\C(\C)=C\C(O)=O,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,7.3,EC50,Tclin
alpelisib,CC1=C(SC(NC(=O)N2CCC[C@H]2C(N)=O)=N1)C1=CC(=NC=C1)C(C)(C)C(F)(F)F,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,8.3372,IC50,Tclin
alpha-Ergocryptine,CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4CC5=CNC6=CC=CC(=C56)C4=C3)(O[C@@]2(O)[C@@H]2CCCN2C1=O)C(C)C,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22184875,IC50,Tclin
alprostadil,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,Cation channel sperm-associated protein 1,Ion channel,Q8NEC5,CATSPER1,CTSR1_HUMAN,6.3,EC50,Tchem
alprostadil,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O,Cation channel sperm-associated protein 2,Ion channel,Q96P56,CATSPER2,CTSR2_HUMAN,6.3,EC50,Tchem
amantadine,NC12CC3CC(CC(C3)C1)C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.69,Ki,Tclin
ambrisentan,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,6.98,Ki,Tclin
ambrisentan,COC([C@H](OC1=NC(C)=CC(C)=N1)C(O)=O)(C1=CC=CC=C1)C1=CC=CC=C1,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,9.65,Ki,Tclin
amfetamine,CC(N)CC1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.935542107,Ki,Tclin
amiloride,NC(=N)NC(=O)C1=C(N)N=C(N)C(Cl)=N1,Amiloride-sensitive sodium channel subunit alpha,Ion channel,P37088,SCNN1A,SCNNA_HUMAN,6.11,IC50,Tclin
amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.6,Ki,Tchem
amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22,Ki,Tclin
amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.168130226,Ki,Tclin
amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7,Ki,Tclin
amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(O1)C=CC=C2,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,7.1,IC50,Tclin
amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.89,Ki,Tclin
amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.25,IC50,Tclin
amlodipine,CCOC(=O)C1=C(COCCN)NC(C)=C(C1C1=C(Cl)C=CC=C1)C(=O)OC,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,7,Ki,Tclin
amoxapine,ClC1=CC=C2OC3=C(C=CC=C3)N=C(N3CCNCC3)C2=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.4225082,Ki,Tclin
anagliptin,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N1CCC[C@H]1C#N,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,7.221848965,IC50,Tchem
anagrelide,ClC1=CC=C2N=C3NC(=O)CN3CC2=C1Cl,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,7.27,IC50,Tclin
anastrozole,CC(C)(C#N)C1=CC(=CC(CN2C=NC=N2)=C1)C(C)(C)C#N,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.2218,IC50,Tclin
androstanolone,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.7,Ki,Tclin
androstanolone,C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.66,Ki,Tclin
androstenediol,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC[C@@H]2O,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,6.64,IC50,Tclin
androstenediol,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC[C@@H]2O,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.74,IC50,Tclin
androstenediol,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC[C@@H]2O,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8,IC50,Tclin
androstenedione,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,7.7,Ki,Tclin
androstenedione,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O,Testosterone 17-beta-dehydrogenase 3,Enzyme,P37058,HSD17B3,DHB3_HUMAN,6.31,IC50,Tchem
angiotensin II,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.3,IC50,Tclin
angiotensin II,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,Type-2 angiotensin II receptor,GPCR,P50052,AGTR2,AGTR2_HUMAN,10.2,Kd,Tchem
apalutamide,CNC(=O)C1=CC=C(C=C1F)N1C(=S)N(C(=O)C11CCC1)C1=CC(=C(N=C1)C#N)C(F)(F)F,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.79588,IC50,Tclin
apatinib,O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,6.367542744,IC50,Tclin
apatinib,O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.275723934,IC50,Tclin
apatinib,O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.886056423,IC50,Tclin
apatinib,O=C(NC1=CC=C(C=C1)C1(CCCC1)C#N)C1=CC=CN=C1NCC1=CC=NC=C1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,9,IC50,Tclin
apixaban,COC1=CC=C(C=C1)N1N=C(C(N)=O)C2=C1C(=O)N(CC2)C1=CC=C(C=C1)N1CCCCC1=O,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,10.1,Ki,Tclin
apremilast,CCOC1=C(OC)C=CC(=C1)[C@@H](CS(C)(=O)=O)N1C(=O)C2=CC=CC(NC(C)=O)=C2C1=O,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,7.130768299,IC50,Tclin
aprepitant,C[C@@H](O[C@H]1OCCN(CC2=NNC(=O)N2)[C@H]1C1=CC=C(F)C=C1)C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F,Neuromedin-K receptor,GPCR,P29371,TACR3,NK3R_HUMAN,6.34,Ki,Tchem
aprotinin,(null),Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,6.8,IC50,Tclin
argatroban,C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)NS(=O)(=O)C1=CC=CC2=C1NCC(C)C2,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,7.39794,Ki,Tclin
astemizole,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.749579998,Ki,Tclin
astemizole,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,6.7,IC50,Tclin
astemizole,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.025028006,Ki,Tclin
astemizole,COC1=CC=C(CCN2CCC(CC2)NC2=NC3=C(C=CC=C3)N2CC2=CC=C(F)C=C2)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.100726813,Ki,Tclin
atropine,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.5,Ki,Tclin
auranofin,(null),Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.222573178,Ki,Tclin
avapritinib,CN1C=C(C=N1)C1=CN2N=CN=C(N3CCN(CC3)C3=NC=C(C=N3)[C@@](C)(N)C3=CC=C(F)C=C3)C2=C1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,9.57,IC50,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,7.14,Kd,Tchem
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,8.89,Kd,Tchem
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6.42,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.96,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.68,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.09,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,6.04,Kd,Tchem
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.68,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,9.31,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,9.24,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,8.38,Ki,Tchem
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.82,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,7.01,Kd,Tchem
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.38,Kd,Tchem
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,8.24,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,8.23,Kd,Tclin
axitinib,CNC(=O)C1=C(SC2=CC=C3C(NN=C3\C=C\C3=CC=CC=N3)=C2)C=CC=C1,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,6.77,Kd,Tclin
baricitinib,CCS(=O)(=O)N1CC(CC#N)(C1)N1C=C(C=N1)C1=NC=NC2=C1C=CN2,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.1,IC50,Tclin
basiliximab,(null),Interleukin-2 receptor subunit alpha,Membrane receptor,P01589,IL2RA,IL2RA_HUMAN,10,Kd,Tclin
bazedoxifene,CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.22,IC50,Tclin
bazedoxifene,CC1=C(N(CC2=CC=C(OCCN3CCCCCC3)C=C2)C2=C1C=C(O)C=C2)C1=CC=C(O)C=C1,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.42,IC50,Tclin
beclometasone dipropionate,CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.427128398,Ki,Tclin
belinostat,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,Histone deacetylase 4,Enzyme,P56524,HDAC4,HDAC4_HUMAN,7.568636417,IC50,Tclin
belinostat,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,8.8,Ki,Tclin
belinostat,ONC(=O)C=CC1=CC(=CC=C1)S(=O)(=O)NC1=CC=CC=C1,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,7.66,Ki,Tclin
benazepril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCC2=CC=CC=C2N(CC(O)=O)C1=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,6.51,IC50,Tclin
bendamustine,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,8.22,IC50,Tclin
bendamustine,CN1C(CCCC(O)=O)=NC2=CC(=CC=C12)N(CCCl)CCCl,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,6.97,IC50,Tclin
benzatropine,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.9586,Ki,Tclin
benzatropine,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(C1=CC=CC=C1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.229147988,Ki,Tclin
benzatropine,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(C1=CC=CC=C1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.2533,Kd,Tclin
benzethonium,CC(C)(C)CC(C)(C)C1=CC=C(OCCOCC[N+](C)(C)CC2=CC=CC=C2)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.091514981,Ki,Tclin
benzylsulfamide,NS(=O)(=O)C1=CC=C(NCC2=CC=CC=C2)C=C1,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.67,Ki,Tclin
bepridil,CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,O00555,CACNA1A,CAC1A_HUMAN,6.6,Ki,Tchem
betamethasone,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.07,IC50,Tclin
betamethasone phosphate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.428291168,Ki,Tclin
betrixaban,COC1=CC=C(NC(=O)C2=CC=C(C=C2)C(=N)N(C)C)C(=C1)C(=O)NC1=CC=C(Cl)C=N1,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,8.823908806,IC50,Tclin
bexarotene,CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,6.74,Ki,Tclin
bexarotene,CC1=C(C=C2C(=C1)C(C)(C)CCC2(C)C)C(=C)C1=CC=C(C=C1)C(O)=O,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,7.3,Ki,Tclin
bicalutamide,CC(O)(CS(=O)(=O)C1=CC=C(F)C=C1)C(=O)NC1=CC(=C(C=C1)C#N)C(F)(F)F,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.72,Ki,Tclin
bietamiverine,CCN(CC)CCOC(=O)C(N1CCCCC1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.73,Ki,Tclin
bifonazole,C1=CN(C=N1)C(C1=CC=CC=C1)C1=CC=C(C=C1)C1=CC=CC=C1,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,7.25,Ki,Tclin
binimetinib,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,7.9,IC50,Tclin
binimetinib,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3F)=C(C=C12)C(=O)NOCCO,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,7.9,IC50,Tclin
biperiden,OC(CCN1CCCCC1)(C1CC2CC1C=C2)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.41,Kd,Tclin
bithionol,OC1=C(SC2=C(O)C(Cl)=CC(Cl)=C2)C=C(Cl)C=C1Cl,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.41453927,IC50,Tchem
bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,8.6,Ki,Tclin
blonanserin,CCN1CCN(CC1)C1=NC2=C(CCCCCC2)C(=C1)C1=CC=C(F)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.54,Ki,Tclin
boceprevir,CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C,Cathepsin K,Enzyme,P43235,CTSK,CATK_HUMAN,7.4,IC50,Tchem
bortezomib,CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,Proteasome subunit beta type-8,Enzyme,P28062,PSMB8,PSB8_HUMAN,8.09,IC50,Tclin
bosentan,COC1=C(OC2=C(OCCO)N=C(N=C2NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C2=NC=CC=N2)C=CC=C1,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,7.1,Ki,Tclin
bosentan,COC1=C(OC2=C(OCCO)N=C(N=C2NS(=O)(=O)C2=CC=C(C=C2)C(C)(C)C)C2=NC=CC=N2)C=CC=C1,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,8.19,Ki,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,6.85,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Dual serine/threonine and tyrosine protein kinase,Kinase,Q6XUX3,DSTYK,DUSTY_HUMAN,6.42,Kd,Tbio
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,7.72,Kd,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,8,Kd,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,8.08,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,8.04,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,6.57,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,6.3,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,6.42,Kd,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.14,Kd,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,7,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.31,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,7.04,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.66,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Peripheral plasma membrane protein CASK,Kinase,O14936,CASK,CSKP_HUMAN,6.08,Kd,Tbio
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,6.7,Kd,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,9,Kd,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,9.11,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,6.24,Kd,Tbio
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,6.72,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,6.92,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,7.52,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Serine/threonine-protein kinase SIK3,Kinase,Q9Y2K2,SIK3,SIK3_HUMAN,7.19,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,10.54,Kd,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,8.32,Kd,Tclin
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,6.96,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,7.28,Kd,Tchem
bosutinib,COC1=CC2=C(C=C1OCCCN1CCN(C)CC1)N=CC(C#N)=C2NC1=CC(OC)=C(Cl)C=C1Cl,Wee1-like protein kinase 2,Kinase,P0C1S8,WEE2,WEE2_HUMAN,7.03,Kd,Tbio
brexpiprazole,O=C1NC2=C(C=C1)C=CC(OCCCCN1CCN(CC1)C1=C3C=CSC3=CC=C1)=C2,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.024568191,IC50,Tclin
brigatinib,COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,6.795879841,IC50,Tclin
brigatinib,COC1=C(NC2=NC=C(Cl)C(NC3=CC=CC=C3P(C)(C)=O)=N2)C=CC(=C1)N1CCC(CC1)N1CCN(C)CC1,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,7.136677265,IC50,Tclin
brinzolamide,CCN[C@H]1CN(CCCOC)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,9.9,Ki,Tclin
bromhexine,CN(CC1=C(N)C(Br)=CC(Br)=C1)C1CCCCC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.602059991,Ki,Tclin
bromperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Br)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,9.02,EC50,Tclin
budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,10.3,EC50,Tclin
budesonide,CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,7.55,EC50,Tclin
buflomedil,COC1=CC(OC)=C(C(=O)CCCN2CCCC2)C(OC)=C1,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.22,Ki,Tchem
bumetanide,CCCCNC1=C(OC2=CC=CC=C2)C(=CC(=C1)C(O)=O)S(N)(=O)=O,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,P05023,ATP1A1,AT1A1_HUMAN,7.52,Kd,Tclin
bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.28,Kd,Tclin
buserelin,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,10.52,EC50,Tclin
buserelin,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,Lutropin-choriogonadotropic hormone receptor,GPCR,P22888,LHCGR,LSHR_HUMAN,8.5686,Kd,Tclin
buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)C1=NC=CC=N1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.3188,Ki,Tclin
cabozantinib,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,8.8860569,IC50,Tclin
cabozantinib,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.337242126,IC50,Tclin
cabozantinib,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.283996582,IC50,Tclin
cabozantinib,COC1=CC2=NC=CC(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3)=C2C=C1OC,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,10.45593166,IC50,Tclin
calcipotriene,C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,9.51,Kd,Tclin
calcitriol,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,8.4,EC50,Tclin
caplacizumab,(null),von Willebrand factor,Unclassified,P04275,VWF,VWF_HUMAN,8.508638306,Kd,Tclin
captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.7,Ki,Tclin
captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,7.32,Ki,Tclin
captopril,C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O,Renin,Enzyme,P00797,REN,RENI_HUMAN,8.77,Ki,Tclin
caramiphen,CCN(CC)CCOC(=O)C1(CCCC1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.81,Ki,Tclin
carbachol,C[N+](C)(C)CCOC(N)=O,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.699,EC50,Tclin
carfilzomib,CC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1,Proteasome subunit beta type-8,Enzyme,P28062,PSMB8,PSB8_HUMAN,7.85,IC50,Tclin
carvedilol,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.17327748,Ki,Tclin
cefapirin,CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSC1=CC=NC=C1)C2=O)C(O)=O,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.21,IC50,Tclin
celecoxib,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.68,IC50,Tclin
celecoxib,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.06,Ki,Tclin
celecoxib,CC1=CC=C(C=C1)C1=CC(=NN1C1=CC=C(C=C1)S(N)(=O)=O)C(F)(F)F,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.18,Ki,Tclin
ceritinib,CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.59,IC50,Tclin
ceritinib,CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.37,IC50,Tclin
ceritinib,CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,8.154901505,IC50,Tclin
ceritinib,CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,8.096910477,IC50,Tclin
ceritinib,CC(C)OC1=C(NC2=NC=C(Cl)C(NC3=C(C=CC=C3)S(=O)(=O)C(C)C)=N2)C=C(C)C(=C1)C1CCNCC1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.4,IC50,Tclin
cetrorelix,CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC=C2C=CC=CC2=C1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,8.8,Ki,Tclin
cevimeline,CC1OC2(CS1)CN1CCC2CC1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.3188,EC50,Tclin
chidamide,NC1=CC(F)=CC=C1NC(=O)C1=CC=C(CNC(=O)\C=C\C2=CC=CN=C2)C=C1,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,6.134895802,IC50,Tclin
chlorambucil,OC(=O)CCCC1=CC=C(C=C1)N(CCCl)CCCl,Cathepsin D,Enzyme,P07339,CTSD,CATD_HUMAN,8.93,IC50,Tchem
chlormadinone,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.764471553,Ki,Tclin
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.25091362,Ki,Tclin
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.723538196,Ki,Tclin
chlorprothixene,CN(C)CC\C=C1\C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.657577319,Ki,Tclin
chlortalidone,NS(=O)(=O)C1=CC(=CC=C1Cl)C1(O)NC(=O)C2=CC=CC=C12,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.71,Ki,Tclin
ciclesonide,CC(C)C(=O)OCC(=O)[C@@]12O[C@@H](O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]21C)C1CCCCC1,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.43,Ki,Tclin
ciclosporin,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q02127,DHODH,PYRD_HUMAN,6.699,IC50,Tclin
ciclosporin,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,Peptidyl-prolyl cis-trans isomerase B,Enzyme,P23284,PPIB,PPIB_HUMAN,8.01,Kd,Tchem
ciclosporin,CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,Enzyme,Q08209,PPP3CA,PP2BA_HUMAN,8.4,Kd,Tchem
cilazapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.7,IC50,Tclin
cilostazol,O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,6.7,IC50,Tclin
cinacalcet,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=C1C=CC=C2,Extracellular calcium-sensing receptor,GPCR,P41180,CASR,CASR_HUMAN,7.7,EC50,Tclin
cinacalcet,C[C@@H](NCCCC1=CC(=CC=C1)C(F)(F)F)C1=CC=CC2=C1C=CC=C2,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.489999771,EC50,Tclin
cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.790484985,Ki,Tclin
cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.769551079,Ki,Tclin
cisapride,COC1CN(CCCOC2=CC=C(F)C=C2)CCC1NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.522878745,IC50,Tclin
cisapride,COC1CN(CCCOC2=CC=C(F)C=C2)CCC1NC(=O)C1=C(OC)C=C(N)C(Cl)=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.378823718,Ki,Tclin
citalopram,CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.777283529,Ki,Tclin
clemastine,CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.083546051,Ki,Tclin
clemastine,CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.853871964,Ki,Tclin
clemastine,CN1CCC[C@@H]1CCO[C@](C)(C1=CC=CC=C1)C1=CC=C(Cl)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.269217724,Ki,Tclin
clidinium,C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.6,Ki,Tclin
clobetasol propionate,CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.179142011,Ki,Tclin
clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,9,Ki,Tchem
clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,8.886056648,Ki,Tclin
clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.35753548,Ki,Tclin
clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.1,Ki,Tclin
clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(Cl)C1=CC=CC=C1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.205511953,Ki,Tclin
clomipramine,CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.443697499,Ki,Tclin
clomipramine,CN(C)CCCN1C2=CC(Cl)=CC=C2CCC2=C1C=CC=C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.242603971,Ki,Tclin
clotrimazole,ClC1=C(C=CC=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,8.74,IC50,Tclin
clotrimazole,ClC1=C(C=CC=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.699,IC50,Tclin
clotrimazole,ClC1=C(C=CC=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,7.0888,IC50,Tclin
clotrimazole,ClC1=C(C=CC=C1)C(N1C=CN=C1)(C1=CC=CC=C1)C1=CC=CC=C1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,7.853871964,IC50,Tchem
clozapine,CN1CCN(CC1)C1=NC2=CC(Cl)=CC=C2NC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.5911,Ki,Tclin
cobimetinib,OC1(CN(C1)C(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1)[C@@H]1CCCCN1,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,9.045757294,IC50,Tclin
cobimetinib,OC1(CN(C1)C(=O)C1=C(NC2=CC=C(I)C=C2F)C(F)=C(F)C=C1)[C@@H]1CCCCN1,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,6.7,IC50,Tclin
colecalciferol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.400000095,EC50,Tclin
colecalciferol,CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,9.68,EC50,Tclin
copanlisib,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,9.301030159,IC50,Tclin
copanlisib,COC1=C(OCCCN2CCOCC2)C=CC2=C1N=C(NC(=O)C1=CN=C(N)N=C1)N1CCN=C21,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,9.154901505,IC50,Tclin
corticotropin,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,Melanocyte-stimulating hormone receptor,GPCR,Q01726,MC1R,MSHR_HUMAN,8.6,Ki,Tclin
cortisone acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.02,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.36,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,6.59,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,7.43,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,6.64,Kd,Tbio
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Dual serine/threonine and tyrosine protein kinase,Kinase,Q6XUX3,DSTYK,DUSTY_HUMAN,6.35,Kd,Tbio
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,6.24,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,9.26,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,7.02,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,6.47,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,6.11,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,LIM domain kinase 1,Kinase,P53667,LIMK1,LIMK1_HUMAN,6.08,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,6.68,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,6.1,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,O15146,MUSK,MUSK_HUMAN,6.64,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.92,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Peripheral plasma membrane protein CASK,Kinase,O14936,CASK,CSKP_HUMAN,6.85,Kd,Tbio
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.25,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,6.24,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Serine/threonine-protein kinase Nek9,Kinase,Q8TD19,NEK9,NEK9_HUMAN,6.1,Kd,Tbio
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,7.22,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.7,Kd,Tclin
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,8.44,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6.96,Kd,Tchem
crizotinib,C[C@@H](OC1=C(N)N=CC(=C1)C1=CN(N=C1)C1CCNCC1)C1=C(Cl)C=CC(F)=C1Cl,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,8.11,Kd,Tchem
cyamemazine,CC(CN(C)C)CN1C2=CC=CC=C2SC2=C1C=C(C=C2)C#N,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.494850159,Ki,Tclin
cyclizine,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.798602876,Ki,Tclin
cyclizine,CN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.217527376,Ki,Tclin
cyclobenzaprine,CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.22184875,Ki,Tclin
cyclobenzaprine,CN(C)CCC=C1C2=CC=CC=C2C=CC2=C1C=CC=C2,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.52,IC50,Tclin
cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8,Ki,Tclin
cyproterone acetate,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.432,IC50,Tclin
cyproterone acetate,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.796,IC50,Tclin
cyproterone acetate,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.678,IC50,Tclin
dabigatran etexilate,CCCCCCOC(=O)NC(=N)C1=CC=C(NCC2=NC3=CC(=CC=C3N2C)C(=O)N(CCC(=O)OCC)C2=NC=CC=C2)C=C1,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,8.35,Ki,Tclin
dabrafenib,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,6.82,IC50,Tclin
dabrafenib,CC(C)(C)C1=NC(=C(S1)C1=NC(N)=NC=C1)C1=C(F)C(NS(=O)(=O)C2=C(F)C=CC=C2F)=CC=C1,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,9.1549015,IC50,Tclin
dacarbazine,CN(C)\N=N\C1=C(NC=N1)C(N)=O,Matrix metalloproteinase-9,Enzyme,P14780,MMP9,MMP9_HUMAN,6.254925208,IC50,Tchem
dacomitinib,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN1CCCCC1,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,7.3400838,IC50,Tclin
dantrolene,[O-][N+](=O)C1=CC=C(C=C1)C1=CC=C(O1)\C=N\N1CC(=O)NC1=O,Ryanodine receptor 1,Ion channel,P21817,RYR1,RYR1_HUMAN,6.757,Ki,Tclin
darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC=C3OCCC3=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.52,Kd,Tclin
darolutamide,C[C@@H](CN1C=CC(=N1)C1=CC=C(C#N)C(Cl)=C1)NC(=O)C1=NNC(=C1)[C@@H](C)O,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.187,IC50,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.21,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Activin receptor type-2B,Kinase,Q13705,ACVR2B,AVR2B_HUMAN,6.24,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,7.28,Kd,Tbio
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,"Chaperone activity of bc1 complex-like, mitochondrial",Kinase,Q8NI60,COQ8A,COQ8A_HUMAN,6.72,Kd,Tbio
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,8.52,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,9.41,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,9.47,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,LIM domain kinase 1,Kinase,P53667,LIMK1,LIMK1_HUMAN,6.24,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,9.24,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,9.24,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,9.2,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,9.68,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.41,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,6.24,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,7.74,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,6.68,Kd,Tbio
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,6.3,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,8.41,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Serine/threonine-protein kinase SIK3,Kinase,Q9Y2K2,SIK3,SIK3_HUMAN,7.55,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Serine/threonine-protein kinase receptor R3,Kinase,P37023,ACVRL1,ACVL1_HUMAN,6.34,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,TGF-beta receptor type-1,Kinase,P36897,TGFBR1,TGFR1_HUMAN,6.64,Kd,Tchem
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,9.6,IC50,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,8.85,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.19,Kd,Tclin
dasatinib,CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1,Wee1-like protein kinase 2,Kinase,P0C1S8,WEE2,WEE2_HUMAN,6.7,Kd,Tbio
degarelix,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC=C(NC(N)=O)C=C1)NC(=O)[C@H](CC1=CC=C(NC(=O)[C@@H]2CC(=O)NC(=O)N2)C=C1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1=CC=C(Cl)C=C1)NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(C)=O)C(=O)N[C@@H](CCCCNC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,8.77,Ki,Tclin
delapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N(CC(O)=O)C1CC2=C(C1)C=CC=C2,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,9.970000267,Ki,Tclin
demeclocycline,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)C4=C(Cl)C=CC(O)=C4C(=O)C3=C(O)[C@]2(O)C(=O)C(C(N)=O)=C1O,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,7.210000038,IC50,Tclin
dequalinium,CC1=[N+](CCCCCCCCCC[N+]2=C(C)C=C(N)C3=CC=CC=C23)C2=CC=CC=C2C(N)=C1,cGMP-gated cation channel alpha-1,Unclassified,P29973,CNGA1,CNGA1_HUMAN,6.7,IC50,(null)
desipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.68,Ki,Tclin
desipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=CC=C2,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,9.31,Ki,Tclin
desirudin,(null),Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,12.7,Ki,Tclin
desloratadine,ClC1=CC=C2C(CCC3=C(N=CC=C3)C2=C2CCNCC2)=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.49,Ki,Tclin
desoximetasone,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.931814138,Ki,Tclin
desoxycortone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.2,IC50,Tclin
dexamethasone,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.88,EC50,Tclin
dexamethasone,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.25,Ki,Tclin
dexamethasone palmitate,CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.26,Ki,Tclin
dexamethasone palmitate,CCCCCCCCCCCCCCCC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.25,Ki,Tclin
dexamethasone phosphate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.3,IC50,Tclin
dexamethasone phosphate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(O)(O)=O,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.25,Ki,Tclin
dexamethasone valerate,CCCCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.26,Ki,Tclin
dexamethasone valerate,CCCCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CO,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.25,Ki,Tclin
dexamfetamine,C[C@H](N)CC1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.68,Ki,Tclin
dexchlorpheniramine,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.262012674,Ki,Tclin
dexchlorpheniramine,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.156767222,Ki,Tclin
dexchlorpheniramine,CN(C)CC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=CC=N1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.131355562,Ki,Tclin
dexfenfluramine,CCN[C@@H](C)CC1=CC(=CC=C1)C(F)(F)F,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.663540266,Ki,Tclin
dexmethylphenidate,COC(=O)[C@@H]([C@H]1CCCCN1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.8,Ki,Tclin
dextromethorphan,COC1=CC2=C(C[C@H]3[C@H]4CCCC[C@@]24CCN3C)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.4584,D2,Tclin
diazepam,CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C1=CC=CC=C1,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,7.639999866,Kd,Tclin
dibrompropamidine,NC(=N)C1=CC(Br)=C(OCCCOC2=C(Br)C=C(C=C2)C(N)=N)C=C1,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.02,Ki,Tclin
dichlorphenamide,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.4202,Ki,Tclin
dichlorphenamide,NS(=O)(=O)C1=CC(Cl)=C(Cl)C(=C1)S(N)(=O)=O,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7.02,Ki,Tclin
diclofenac,OC(=O)CC1=C(NC2=C(Cl)C=CC=C2Cl)C=CC=C1,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,6.2,Ki,Tclin
dicoumarol,OC1=C(CC2=C(O)C3=C(OC2=O)C=CC=C3)C(=O)OC2=CC=CC=C12,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,7.41,Ki,Tchem
dicycloverine,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.032920266,Ki,Tclin
dicycloverine,CCN(CC)CCOC(=O)C1(CCCCC1)C1CCCCC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.68613278,Ki,Tclin
diethylstilbestrol,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.66,Ki,Tclin
diethylstilbestrol,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,9.2,Ki,Tclin
diethylstilbestrol,CC\C(=C(\CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.07007044,Ki,Tclin
diflorasone diacetate,C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(C)=O)C(=O)COC(C)=O,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.536107011,Ki,Tclin
diflunisal,OC(=O)C1=C(O)C=CC(=C1)C1=C(F)C=C(F)C=C1,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,7.125,Kd1,Tclin
digitoxin,C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]1[C@@H](O)C[C@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3CC[C@@]4(C)[C@H](CC[C@@H]5[C@@H]4CC[C@]4(C)[C@H](CC[C@]54O)C4=CC(=O)OC4)C3)O[C@@H]2C)O[C@@H]1C,Signal transducer and activator of transcription 3,Transcription factor,P40763,STAT3,STAT3_HUMAN,6.150000095,IC50,Tchem
diiodohydroxyquinoline,OC1=C2N=CC=CC2=C(I)C=C1I,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.53165267,IC50,Tchem
diltiazem,COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,7.3188,IC50,Tclin
diltiazem,COC1=CC=C(C=C1)[C@@H]1SC2=CC=CC=C2N(CCN(C)C)C(=O)[C@@H]1OC(C)=O,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6.42,Ki,Tclin
dimenhydrinate,(null),Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.022276395,Ki,Tclin
dimenhydrinate,(null),Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.312471039,Ki,Tclin
dimetindene,CC(C1=C(CCN(C)C)CC2=C1C=CC=C2)C1=CC=CC=N1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.72,Ki,Tclin
dinoprostone,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,Cation channel sperm-associated protein 1,Ion channel,Q8NEC5,CATSPER1,CTSR1_HUMAN,6.3,EC50,Tchem
dinoprostone,CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O,Cation channel sperm-associated protein 2,Ion channel,Q96P56,CATSPER2,CTSR2_HUMAN,6.3,EC50,Tchem
diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.6402,Ki,Tclin
diphenidol,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.283996656,Ki,Tclin
diphenidol,OC(CCCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.966576245,Ki,Tclin
diphenylpyraline,CN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.3767,IC50,Tclin
dipyridamole,OCCN(CCO)C1=NC(N2CCCCC2)=C2N=C(N=C(N3CCCCC3)C2=N1)N(CCO)CCO,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,6.4,Ki,Tchem
dobutamine,CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.32,Ki,Tclin
dobutamine,CC(CCC1=CC=C(O)C=C1)NCCC1=CC=C(O)C(O)=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.910094889,Ki,Tclin
dofetilide,CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,7.5,IC50,Tclin
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.84,Ki,Tclin
dorzolamide,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,9.7,Ki,Tclin
dorzolamide,CCN[C@H]1C[C@H](C)S(=O)(=O)C2=C1C=C(S2)S(N)(=O)=O,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7.37,Ki,Tclin
dosulepin,CN(C)CC\C=C1/C2=CC=CC=C2CSC2=CC=CC=C12,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.4202,Ki,Tclin
doxazosin,COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1COC2=C(O1)C=CC=C2,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.826813732,Ki,Tclin
doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.284,Ki,Tclin
doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=CC=C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.576754126,Ki,Tclin
doxorubicin,COC1=C2C(=O)C3=C(C(O)=C4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O)C(=O)CO)C(=O)C2=CC=C1,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,7.4,IC50,Tchem
drospirenone,C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.5,IC50,Tclin
drospirenone,C[C@]12CC[C@H]3[C@@H]([C@H]4C[C@H]4C4=CC(=O)CC[C@]34C)[C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,10.5,EC50,Tclin
duloxetine,CNCC[C@H](OC1=CC=CC2=C1C=CC=C2)C1=CC=CS1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.62,Ki,Tclin
dutasteride,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC1=C(C=CC(=C1)C(F)(F)F)C(F)(F)F,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,P31213,SRD5A2,S5A2_HUMAN,9.2,IC50,Tclin
dutasteride,C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)C=C[C@]34C)[C@@H]1CC[C@@H]2C(=O)NC1=C(C=CC(=C1)C(F)(F)F)C(F)(F)F,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.480000019,EC50,Tclin
duvelisib,C[C@H](NC1=NC=NC2=C1N=CN2)C1=CC2=C(C(Cl)=CC=C2)C(=O)N1C1=CC=CC=C1,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,10.63827216,Kd,Tclin
dydrogesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.9,Ki,Tclin
ebastine,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.862645889,Ki,Tclin
ebastine,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN1CCC(CC1)OC(C1=CC=CC=C1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.105683937,Ki,Tclin
econazole,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.301029996,IC50,Tclin
econazole,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.42136079,Ki,Tclin
econazole,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.178486472,Ki,Tclin
econazole,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,6.49,Ki,Tclin
econazole,ClC1=CC=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,7.537602002,IC50,Tchem
edoxaban,CN(C)C(=O)[C@H]1CC[C@H](NC(=O)C(=O)NC2=CC=C(Cl)C=N2)[C@@H](C1)NC(=O)C1=NC2=C(CN(C)CC2)S1,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,9.251811981,Ki,Tclin
elagolix,COC1=CC=CC(=C1F)C1=C(C)N(CC2=C(F)C=CC=C2C(F)(F)F)C(=O)N(C[C@H](NCCCC(O)=O)C2=CC=CC=C2)C1=O,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,8.823908741,IC50,Tclin
eledoisin,CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O,Neuromedin-K receptor,GPCR,P29371,TACR3,NK3R_HUMAN,9.66,EC50,Tchem
elliptinium,CC1=C2C=C[N+](C)=CC2=C(C)C2=C1NC1=CC=C(O)C=C21,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.3,IC50,Tclin
elliptinium,CC1=C2C=C[N+](C)=CC2=C(C)C2=C1NC1=CC=C(O)C=C21,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,6.4,IC50,Tclin
enalaprilat,C[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,7.5,IC50,Tclin
enasidenib,CC(C)(O)CNC1=NC(=NC(NC2=CC(=NC=C2)C(F)(F)F)=N1)C1=CC=CC(=N1)C(F)(F)F,"Isocitrate dehydrogenase [NADP], mitochondrial",Enzyme,P48735,IDH2,IDHP_HUMAN,7,IC50,Tclin
encorafenib,COC(=O)N[C@@H](C)CNC1=NC(=CC=N1)C1=CN(N=C1C1=C(F)C(NS(C)(=O)=O)=CC(Cl)=C1)C(C)C,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,9.522879,IC50,Tclin
encorafenib,COC(=O)N[C@@H](C)CNC1=NC(=CC=N1)C1=CN(N=C1C1=C(F)C(NS(C)(=O)=O)=CC(Cl)=C1)C(C)C,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,9.327902,IC50,Tclin
enfortumab vedotin,(null),Nectin-4,Tumour-associated antigen,Q96NY8,NECTIN4,NECT4_HUMAN,10.24,Ki,Tclin
entacapone,CCN(CC)C(=O)C(=C\C1=CC(=C(O)C(O)=C1)[N+]([O-])=O)\C#N,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,9.522878647,Ki,Tclin
entrectinib,CN1CCN(CC1)C1=CC(NC2CCOCC2)=C(C=C1)C(=O)NC1=NNC2=CC=C(CC3=CC(F)=CC(F)=C3)C=C12,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,8.52,IC50,Tclin
entrectinib,CN1CCN(CC1)C1=CC(NC2CCOCC2)=C(C=C1)C(=O)NC1=NNC2=CC=C(CC3=CC(F)=CC(F)=C3)C=C12,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,9,IC50,Tclin
enzalutamide,CNC(=O)C1=C(F)C=C(C=C1)N1C(=S)N(C(=O)C1(C)C)C1=CC(=C(C=C1)C#N)C(F)(F)F,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.31,EC50,Tclin
eperisone,CCC1=CC=C(C=C1)C(=O)C(C)CN1CCCCC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.769551079,Ki,Tclin
eprosartan,CCCCC1=NC=C(\C=C(/CC2=CC=CS2)C(O)=O)N1CC1=CC=C(C=C1)C(O)=O,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,8.7,IC50,Tclin
erdafitinib,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,8.9208,IC50,Tclin
erdafitinib,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,8.6021,IC50,Tclin
erdafitinib,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,8.5229,IC50,Tclin
erdafitinib,COC1=CC(=CC(OC)=C1)N(CCNC(C)C)C1=CC2=NC(=CN=C2C=C1)C1=CN(C)N=C1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,7.4342,IC50,Tclin
erlotinib,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.22,Kd,Tchem
erlotinib,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,Citron Rho-interacting kinase,Kinase,O14578,CIT,CTRO_HUMAN,6.17,Kd,Tbio
erlotinib,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.15,Kd,Tclin
erlotinib,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.48,Kd,Tclin
erlotinib,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,7.24,Kd,Tclin
erlotinib,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.15,Kd,Tclin
erlotinib,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,6.01,Kd,Tchem
erlotinib,COCCOC1=CC2=C(C=C1OCCOC)C(NC1=CC=CC(=C1)C#C)=NC=N2,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6.07,Kd,Tchem
estradiol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@H]2O,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.72,IC50,Tclin
estradiol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@H]2O,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,10.3,EC50,Tclin
estradiol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@H]2O,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,9.7,EC50,Tclin
estradiol benzoate,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(OC(=O)C3=CC=CC=C3)=C4)[C@@H]1CC[C@@H]2O,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,7.744727495,Ki,Tclin
estriol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,8.67,Ki,Tclin
estriol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1C[C@@H](O)[C@@H]2O,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.4,Ki,Tclin
estriol succinate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=CC=C34)[C@@H]1C[C@@H](OC(=O)CCC(O)=O)[C@@H]2OC(=O)CCC(O)=O,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.319999695,Ki,Tclin
estriol succinate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(O)=CC=C34)[C@@H]1C[C@@H](OC(=O)CCC(O)=O)[C@@H]2OC(=O)CCC(O)=O,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,9.899999619,EC50,Tclin
estrone,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.15,EC50,Tclin
estrone,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CCC2=O,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.68,EC50,Tclin
eszopiclone,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,7.300000191,Ki,Tclin
eszopiclone,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,6.94,Ki,Tclin
eszopiclone,CN1CCN(CC1)C(=O)O[C@@H]1N(C(=O)C2=NC=CN=C12)C1=CC=C(Cl)C=N1,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,6.789999962,Ki,Tclin
ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.25,IC50,Tclin
ethinylestradiol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.3,IC50,Tclin
ethinylestradiol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.83,Kd,Tclin
ethinylestradiol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.09,IC50,Tclin
ethinylestradiol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.109578981,Ki,Tclin
ethinylestradiol,C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(O)=C4)[C@@H]1CC[C@@]2(O)C#C,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.35261703,Ki,Tclin
ethisterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@]2(O)C#C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.022276395,Ki,Tclin
ethoxzolamide,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,9.31,Ki,Tclin
ethoxzolamide,CCOC1=CC2=C(C=C1)N=C(S2)S(N)(=O)=O,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7.03,Ki,Tclin
ethylestrenol,CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@]12C,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.494850022,Ki,Tclin
etilamfetamine,CCNC(C)CC1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.179999828,Ki,Tclin
etomidate,CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,9.3,IC50,Tclin
everolimus,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OCCO,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,8.7,IC50,Tclin
evocalcet,C[C@@H](N[C@H]1CCN(C1)C1=CC=C(CC(O)=O)C=C1)C1=CC=CC2=CC=CC=C12,Extracellular calcium-sensing receptor,GPCR,P41180,CASR,CASR_HUMAN,7.031517051,EC50,Tclin
fadrozole,N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,10.3,Ki,Tclin
fadrozole,N#CC1=CC=C(C=C1)C1CCCC2=CN=CN12,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,8.2,IC50,Tclin
felodipine,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(Cl)C(Cl)=CC=C1)C(=O)OC,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,8.4,Ki,Tclin
femoxetine,COC1=CC=C(OC[C@H]2CN(C)CC[C@@H]2C2=CC=CC=C2)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.657577319,Ki,Tclin
fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C1=CC=C(Cl)C=C1,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,6.24,EC50,Tclin
fesoterodine,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(OC(=O)C(C)C)C=CC(CO)=C1)C(C)C,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.2706,Ki,Tclin
fimasartan,CCCCC1=NC(C)=C(CC(=S)N(C)C)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.376750946,IC50,Tclin
finasteride,CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,P31213,SRD5A2,S5A2_HUMAN,8.26,IC50,Tclin
floxacillin,CC1=C(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(O)=O)C(=NO1)C1=C(Cl)C=CC=C1F,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,6.25,IC50,Tclin
fludrocortisone acetate,CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.2,EC50,Tclin
fludroxycortide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.694648631,Ki,Tclin
flufenamic acid,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)C=CC=C1,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,7.25,Kd,Tclin
flumazenil,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,8.699999809,Kd,Tclin
flumazenil,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,8.239999771,Ki,Tclin
flumazenil,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,8.090000153,Ki,Tclin
flumazenil,CCOC(=O)C1=C2CN(C)C(=O)C3=CC(F)=CC=C3N2C=N1,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,9.300000191,Kd,Tclin
flunarizine,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.504455662,Ki,Tclin
flunarizine,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8,Ki,Tclin
flunarizine,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,Sodium channel protein type 1 subunit alpha,Ion channel,P35498,SCN1A,SCN1A_HUMAN,6.2,IC50,Tclin
flunarizine,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.333482019,Ki,Tclin
flunarizine,FC1=CC=C(C=C1)C(N1CCN(C\C=C\C2=CC=CC=C2)CC1)C1=CC=C(F)C=C1,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,6.28,Kd,Tclin
flunisolide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.1,EC50,Tclin
flunitrazepam,CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,8.28,Ki,Tclin
flunitrazepam,CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,8.28,Ki,Tclin
flunitrazepam,CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,7.8,Ki,Tclin
flunitrazepam,CN1C2=CC=C(C=C2C(=NCC1=O)C1=C(F)C=CC=C1)[N+]([O-])=O,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,8.26,Ki,Tclin
fluocinolone acetonide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.847711656,Ki,Tclin
fluocinonide,CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]21C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.621602099,Ki,Tclin
fluorometholone,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.801342913,Ki,Tclin
fluorometholone acetate,C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]2(C)C=CC(=O)C=C12,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.34679985,Ki,Tclin
fluoxetine,CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.07,IC50,Tclin
fluoxymesterone,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.24,Ki,Tclin
flupentixol,OCCN1CCN(CCC=C2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.65,IC50,Tclin
fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C=C23)C(F)(F)F)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.066512712,Ki,Tclin
fluticasone furoate,C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)SCF,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,10.12,IC50,Tclin
fluticasone propionate,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,10.74,EC50,Tclin
fluticasone propionate,CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.77,EC50,Tclin
fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.44,Ki,Tclin
fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,8.84,Ki,Tclin
formestane,C[C@]12CC[C@H]3[C@@H](CCC4=C(O)C(=O)CC[C@]34C)[C@@H]1CCC2=O,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,7.5686,Ki,Tclin
forodesine,OC[C@H]1N[C@H]([C@H](O)[C@@H]1O)C1=CNC2=C1NC=NC2=O,Purine nucleoside phosphorylase,Enzyme,P00491,PNP,PNPH_HUMAN,10.14266777,Ki,Tclin
fosinopril,CCC(=O)O[C@@H](O[P@](=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,9,IC50,Tclin
fulvestrant,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC1=CC(O)=CC=C31,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.62,Ki,Tclin
fulvestrant,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC1=CC(O)=CC=C31,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.74,Ki,Tclin
fulvestrant,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)CC1=CC(O)=CC=C31,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.68,IC50,Tclin
furosemide,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.19,Ki,Tclin
furosemide,NS(=O)(=O)C1=CC(C(O)=O)=C(NCC2=CC=CO2)C=C1Cl,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.25,Ki,Tclin
gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,6.1,Kd,Tchem
gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,6.1,Kd,Tchem
gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.64,Kd,Tclin
gemfibrozil,CC1=CC(OCCCC(C)(C)C(O)=O)=C(C)C=C1,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,7,Kd,Tclin
gentian violet,CN(C)C1=CC=C(C=C1)C(C1=CC=C(C=C1)N(C)C)=C1C=CC(C=C1)=[N+](C)C,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.037157319,Ki,Tclin
gimeracil,OC1=CC(=O)NC=C1Cl,Dihydropyrimidine dehydrogenase [NADP(+)],Enzyme,Q12882,DPYD,DPYD_HUMAN,6.638272285,Ki,Tclin
glasdegib,CN1CC[C@H](C[C@@H]1C1=NC2=C(N1)C=CC=C2)NC(=O)NC1=CC=C(C=C1)C#N,Smoothened homolog,GPCR,Q99835,SMO,SMO_HUMAN,8.301029996,IC50,Tclin
glutamic acid,N[C@@H](CCC(O)=O)C(O)=O,Glutamate receptor 2,Ion channel,P42262,GRIA2,GRIA2_HUMAN,6.03000021,Ki,Tclin
glutamic acid,N[C@@H](CCC(O)=O)C(O)=O,Glutamate receptor 3,Ion channel,P42263,GRIA3,GRIA3_HUMAN,6.595166283,Ki,Tclin
glutamic acid,N[C@@H](CCC(O)=O)C(O)=O,Glutamate receptor 4,Ion channel,P48058,GRIA4,GRIA4_HUMAN,6.059999943,Ki,Tclin
glycopyrronium bromide,C[N+]1(C)CCC(C1)OC(=O)C(O)(C1CCCC1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.640000343,Ki,Tclin
gonadorelin,CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,8,IC50,Tclin
gramicidin,(null),Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.111259039,IC50,Tchem
halcinonide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.135488919,Ki,Tclin
haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,6.72,Ki,Tchem
haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,6.2,IC50,Tclin
haloperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC=C(Cl)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.92,EC50,Tclin
hesperetin,COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.99,Ki,Tclin
hexachlorophene,OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(Cl)C(Cl)=CC(Cl)=C1O,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,7.010000229,IC50,Tclin
hexachlorophene,OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(Cl)C(Cl)=CC(Cl)=C1O,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.707743929,IC50,Tchem
hexamidine,NC(=N)C1=CC=C(OCCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.65,Ki,Tclin
hexestrol,CC[C@@H]([C@@H](CC)C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,10.3,Ki,Tclin
hexocyclium,C[N+]1(C)CCN(CC(O)(C2CCCCC2)C2=CC=CC=C2)CC1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.9,Ki,Tclin
homatropine,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.795880017,Ki,Tclin
hydrocortisone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.5,EC50,Tclin
hydroquinone,OC1=CC=C(O)C=C1,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.05,Ki,Tclin
hydroxyprogesterone caproate,CCCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.638272164,Ki,Tclin
hydroxyprogesterone caproate,CCCCCC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,7.663540363,IC50,Tclin
hyoscyamine,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.8,Ki,Tclin
ibrutinib,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.55,IC50,Tclin
ibrutinib,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.721246,IC50,Tclin
ibrutinib,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.43,IC50,Tclin
ibrutinib,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,8.19382,IC50,Tclin
ibrutinib,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,9.14266777,Ki,Tclin
ibrutinib,NC1=C2C(=NC=N1)N(N=C2C1=CC=C(OC2=CC=CC=C2)C=C1)[C@@H]1CCCN(C1)C(=O)C=C,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,7.49485,IC50,Tclin
ibudilast,CC(C)C(=O)C1=C2C=CC=CN2N=C1C(C)C,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,6.78,IC50,Tclin
idelalisib,CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,P42336,PIK3CA,PK3CA_HUMAN,6.086185932,IC50,Tclin
idelalisib,CC[C@H](NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,O00329,PIK3CD,PK3CD_HUMAN,8.602060318,IC50,Tclin
ifenprodil,CC(C(O)C1=CC=C(O)C=C1)N1CCC(CC2=CC=CC=C2)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.41,IC50,Tclin
iloperidone,COC1=C(OCCCN2CCC(CC2)C2=NOC3=CC(F)=CC=C23)C=CC(=C1)C(C)=O,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.19,IC50,Tclin
imatinib,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.52,Ki,Tclin
imatinib,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,7.82,Kd,Tchem
imatinib,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.96,Kd,Tclin
imatinib,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.89,Kd,Tclin
imatinib,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.85,Kd,Tclin
imatinib,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.70333481,IC50,Tchem
imatinib,CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=C3)=C2)CC1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.96,Kd,Tclin
imidafenacin,CC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.498940468,Kb,Tclin
imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.2218,Ki,Tclin
imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.284,Ki,Tclin
indapamide,CC1CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.7,Kd,Tclin
indapamide,CC1CC2=C(C=CC=C2)N1NC(=O)C1=CC(=C(Cl)C=C1)S(N)(=O)=O,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.67,Ki,Tclin
indinavir,CC(C)(C)NC(=O)[C@@H]1CN(CC2=CN=CC=C2)CCN1C[C@@H](O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]1[C@H](O)CC2=C1C=CC=C2,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.397940009,IC50,Tclin
indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.85,EC50,Tclin
indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(O)=O,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,7.38,Kd,Tclin
ingenol mebutate,C\C=C(\C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C,Protein kinase C delta type,Kinase,Q05655,PRKCD,KPCD_HUMAN,8.32790184,EC50,Tclin
ingenol mebutate,C\C=C(\C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C,Protein kinase C gamma type,Kinase,P05129,PRKCG,KPCG_HUMAN,9.79,Ki,Tchem
ingenol mebutate,C\C=C(\C)C(=O)O[C@H]1C(C)=C[C@@]23[C@H](C)C[C@@H]4[C@H]([C@H](C=C(CO)[C@@H](O)[C@]12O)C3=O)C4(C)C,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,7.522878647,EC50,Tchem
ipratropium,CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(CO)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.2924,Ki,Tclin
irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.1,Ki,Tclin
isoconazole,ClC1=CC=C([C@H](CN2C=CN=C2)OCC2=C(Cl)C=CC=C2Cl)C(Cl)=C1,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,6.21,Ki,Tclin
isotretinoin,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.335358024,IC50,Tchem
isotretinoin,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,8.2291,ED50,Tclin
isradipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC=CC2=NON=C12)C(=O)OC(C)C,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,9.3,IC50,Tclin
itraconazole,CCC(C)N1N=CN(C1=O)C1=CC=C(C=C1)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=NC=N3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.045757491,IC50,Tclin
ivacaftor,CC(C)(C)C1=CC(=C(NC(=O)C2=CNC3=CC=CC=C3C2=O)C=C1O)C(C)(C)C,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,8.52,EC50,Tclin
ivosidenib,FC1=CN=CC(=C1)N([C@H](C(=O)NC1CC(F)(F)C1)C1=CC=CC=C1Cl)C(=O)[C@@H]1CCC(=O)N1C1=NC=CC(=C1)C#N,Isocitrate dehydrogenase [NADP] cytoplasmic,Enzyme,O75874,IDH1,IDHC_HUMAN,7.148741651,IC50,Tclin
kainic acid,CC(=C)[C@H]1CN[C@@H]([C@H]1CC(O)=O)C(O)=O,"Glutamate receptor ionotropic, kainate 2",Ion channel,Q13002,GRIK2,GRIK2_HUMAN,7.49,Ki,Tclin
ketanserin,FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,9,IC50,Tclin
ketanserin,FC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,6.1549,Ki,Tclin
ketoconazole,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",Enzyme,Q07973,CYP24A1,CP24A_HUMAN,6.5058,IC50,Tchem
ketoconazole,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.4,Ki,Tclin
ketoconazole,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,6.896196365,IC50,Tclin
ketoconazole,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7,Ki,Tclin
ketoconazole,CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=C(Cl)C=C(Cl)C=C2)C=C1,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,7.28,IC50,Tclin
ketotifen,CN1CCC(CC1)=C1C2=C(SC=C2)C(=O)CC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.5771,Ki,Tclin
labetalol,CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.117475462,Ki,Tclin
lacidipine,CCOC(=O)C1=C(C)NC(C)=C(C1C1=C(\C=C\C(=O)OC(C)(C)C)C=CC=C1)C(=O)OCC,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.045757491,IC50,Tclin
lacosamide,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.48,Ki,Tclin
lacosamide,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.28,Ki,Tclin
lacosamide,COC[C@@H](NC(C)=O)C(=O)NCC1=CC=CC=C1,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,6.74,IC50,Tclin
lansoprazole,CC1=C(CS(=O)C2=NC3=C(N2)C=CC=C3)N=CC=C1OCC(F)(F)F,Microtubule-associated protein tau,Structural,P10636,MAPT,TAU_HUMAN,8.6,Ki,Tchem
lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C1=CC=C2N=CN=C(NC3=CC(Cl)=C(OCC4=CC(F)=CC=C4)C=C3)C2=C1,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,8.15,Kd,Tclin
larotrectinib,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=CC(F)=CC=C1F,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,8.091514981,IC50,Tclin
larotrectinib,O[C@H]1CCN(C1)C(=O)NC1=C2N=C(C=CN2N=C1)N1CCC[C@@H]1C1=CC(F)=CC=C1F,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,8.187086643,IC50,Tclin
lasofoxifene,OC1=CC=C2C(C(CCC2=C1)C1=CC=CC=C1)C1=CC=C(OCCN2CCCC2)C=C1,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,8.89,IC50,Tclin
lasofoxifene,OC1=CC=C2C(C(CCC2=C1)C1=CC=CC=C1)C1=CC=C(OCCN2CCCC2)C=C1,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8.74,IC50,Tclin
lenvatinib,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,7.337242126,IC50,Tclin
lenvatinib,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7,IC50,Tclin
lenvatinib,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.408935547,IC50,Tclin
lenvatinib,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.82,Ki,Tclin
lenvatinib,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,7.657577515,IC50,Tclin
lenvatinib,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,8.397939682,IC50,Tclin
lenvatinib,COC1=CC2=C(C=C1C(N)=O)C(OC1=CC=C(NC(=O)NC3CC3)C(Cl)=C1)=CC=N2,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,8.283996582,IC50,Tclin
lepirudin,(null),Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,13,Ki,Tclin
letrozole,N#CC1=CC=C(C=C1)C(N1C=NC=N1)C1=CC=C(C=C1)C#N,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,8.22,IC50,Tclin
leuprorelin,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,9.5229,IC50,Tclin
levobunolol,CC(C)(C)NC[C@H](O)COC1=C2CCCC(=O)C2=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.488116639,Ki,Tclin
levonorgestrel,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.167491087,Ki,Tclin
levonorgestrel,CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,12.7959,ED50,Tclin
liothyronine,N[C@@H](CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(O)=O,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,10.24,Kd,Tclin
lisinopril,NCCCC[C@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.92,IC50,Tclin
lobeglitazone,COC1=CC=C(OC2=CC(=NC=N2)N(C)CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,7.744727612,EC50,Tclin
lodoxamide,OC(=O)C(=O)NC1=CC(=CC(NC(=O)C(O)=O)=C1Cl)C#N,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,8.79317379,EC50,Tchem
lofepramine,CN(CCCN1C2=CC=CC=C2CCC2=C1C=CC=C2)CC(=O)C1=CC=C(Cl)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.8861,Ki,Tclin
lomitapide,FC(F)(F)CNC(=O)C1(CCCCN2CCC(CC2)NC(=O)C2=C(C=CC=C2)C2=CC=C(C=C2)C(F)(F)F)C2=CC=CC=C2C2=C1C=CC=C2,Microsomal triglyceride transfer protein large subunit,Cytosolic other,P55157,MTTP,MTP_HUMAN,8.09691,IC50,Tclin
loperamide,CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.578396073,Ki,Tclin
lorlatinib,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,7.638272164,IC50,Tclin
lorlatinib,C[C@H]1OC2=C(N)N=CC(=C2)C2=C(C#N)N(C)N=C2CN(C)C(=O)C2=CC=C(F)C=C12,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,7.619788758,IC50,Tclin
losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,7.72,IC50,Tclin
losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.48,IC50,Tclin
loxapine,CN1CCN(CC1)C1=NC2=C(OC3=CC=C(Cl)C=C13)C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.913640022,Ki,Tclin
lumacaftor,CC1=CC=C(NC(=O)C2(CC2)C2=CC=C3OC(F)(F)OC3=C2)N=C1C1=CC=CC(=C1)C(O)=O,Cystic fibrosis transmembrane conductance regulator,Ion channel,P13569,CFTR,CFTR_HUMAN,6.45593214,EC50,Tclin
luspatercept,(null),Growth/differentiation factor 11,Cytokine,O95390,GDF11,GDF11_HUMAN,10.13,Kd,Tclin
lutropin alfa,(null),Lutropin-choriogonadotropic hormone receptor,GPCR,P22888,LHCGR,LSHR_HUMAN,10.9,IC50,Tclin
macitentan,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,Endothelin B receptor,GPCR,P24530,EDNRB,EDNRB_HUMAN,6.407823086,IC50,Tclin
macitentan,CCCNS(=O)(=O)NC1=C(C(OCCOC2=NC=C(Br)C=N2)=NC=N1)C1=CC=C(Br)C=C1,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,9.301030159,IC50,Tclin
mafenide,NCC1=CC=C(C=C1)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.77,Ki,Tclin
maprotiline,CNCCCC12CCC(C3=CC=CC=C13)C1=C2C=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7,Ki,Tclin
masoprocol,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,7.96,IC50,Tclin
masoprocol,C[C@@H](CC1=CC(O)=C(O)C=C1)[C@H](C)CC1=CC(O)=C(O)C=C1,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,6.05,IC50,Tclin
mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.63,IC50,Tclin
mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,8,Ki,Tclin
mecamylamine,CNC1(C)C2CCC(C2)C1(C)C,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,P32297,CHRNA3,ACHA3_HUMAN,6.41,IC50,Tclin
mecasermin,(null),Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,8.309803963,IC50,Tclin
medroxyprogesterone,C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.2,EC50,Tclin
medroxyprogesterone,C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.88,Ki,Tclin
medroxyprogesterone,C[C@H]1C[C@H]2[C@@H]3CC[C@](OC(C)=O)(C(C)=O)[C@@]3(C)CC[C@@H]2[C@@]2(C)CCC(=O)C=C12,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.59,EC50,Tclin
mefenamic acid,CC1=CC=CC(NC2=C(C=CC=C2)C(O)=O)=C1C,Aldo-keto reductase family 1 member C2,Enzyme,P52895,AKR1C2,AK1C2_HUMAN,6.66,Ki,Tchem
megestrol acetate,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.057000407,Ki,Tclin
melatonin,COC1=CC2=C(NC=C2CCNC(C)=O)C=C1,Nuclear receptor ROR-alpha,Nuclear hormone receptor,P35398,RORA,RORA_HUMAN,9,EC50,Tchem
mepacrine,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=CC(Cl)=CC=C12,Major prion protein,Surface antigen,P04156,PRNP,PRIO_HUMAN,6.52,EC50,Tchem
mepacrine,CCN(CC)CCCC(C)NC1=C2C=C(OC)C=CC2=NC2=CC(Cl)=CC=C12,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.575118363,Ki,Tclin
mepenzolate,C[N+]1(C)CCCC(C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.59,Ki,Tclin
mepyramine,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.1837587,Ki,Tclin
mepyramine,COC1=CC=C(CN(CCN(C)C)C2=CC=CC=N2)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.155522824,Ki,Tclin
mequitazine,C(C1CN2CCC1CC2)N1C2=CC=CC=C2SC2=CC=CC=C12,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.27572413,Ki,Tclin
mesoridazine,CN1CCCCC1CCN1C2=CC=CC=C2SC2=C1C=C(C=C2)S(C)=O,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.045757294,Ki,Tclin
mestranol,COC1=CC2=C(C=C1)[C@H]1CC[C@@]3(C)[C@@H](CC[C@@]3(O)C#C)[C@@H]1CC2,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,8.282329497,Ki,Tclin
metergoline,CN1C=C2C[C@@H]3[C@H](C[C@@H](CNC(=O)OCC4=CC=CC=C4)CN3C)C3=CC=CC1=C23,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.301029996,Ki,Tclin
methamphetamine,CN[C@@H](C)CC1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.610834122,Ki,Tclin
methazolamide,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.05,Ki,Tclin
methazolamide,CN1N=C(SC1=NC(C)=O)S(N)(=O)=O,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.62,Ki,Tclin
methscopolamine,C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,10.4,Ki,Tclin
methylphenidate,COC(=O)C(C1CCCCN1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.96,Ki,Tclin
methylprednisolone,C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8.5,EC50,Tclin
methyltestosterone,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.66,EC50,Tclin
methyltestosterone,C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.076755981,Ki,Tclin
methysergide,CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2CC3=CN(C)C4=CC=CC(=C34)C2=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.04,IC50,Tclin
metyrapone,CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,7.84,IC50,Tclin
metyrapone,CC(C)(C(=O)C1=CN=CC=C1)C1=CN=CC=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.096910013,IC50,Tclin
mianserin,CN1CCN2C(C1)C1=C(CC3=C2C=CC=C3)C=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.525783736,Ki,Tclin
mibefradil,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22,Ki,Tclin
mibefradil,COCC(=O)O[C@]1(CCN(C)CCCC2=NC3=C(N2)C=CC=C3)CCC2=CC(F)=CC=C2[C@@H]1C(C)C,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,6.7,IC50,Tclin
miconazole,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.22,IC50,Tclin
miconazole,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7,IC50,Tclin
miconazole,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.175223538,Ki,Tclin
miconazole,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,6.61,Ki,Tclin
miconazole,ClC1=CC(Cl)=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.580044252,IC50,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Aurora kinase A,Kinase,O14965,AURKA,AURKA_HUMAN,7.1,IC50,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.77,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,6.51,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,Q13555,CAMK2G,KCC2G_HUMAN,6.85,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Casein kinase II subunit alpha,Kinase,P68400,CSNK2A1,CSK21_HUMAN,6.6,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,7,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,7.41,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.25,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,6.42,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,6.75,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,6.85,IC50,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.11,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,6.89,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.66,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,7.2,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,6.05,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,6.96,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Protein kinase C delta type,Kinase,Q05655,PRKCD,KPCD_HUMAN,6.5,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.7,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,RAC-alpha serine/threonine-protein kinase,Kinase,P31749,AKT1,AKT1_HUMAN,6.02,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,RAC-beta serine/threonine-protein kinase,Kinase,P31751,AKT2,AKT2_HUMAN,6.11,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,6.13,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,7.77,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,6.75,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,7.18,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,6.8,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Serine/threonine-protein kinase SIK3,Kinase,Q9Y2K2,SIK3,SIK3_HUMAN,7.01,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Serine/threonine-protein kinase STK11,Kinase,Q15831,STK11,STK11_HUMAN,6.46,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.1,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,7.92,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.21,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,U4/U6 small nuclear ribonucleoprotein Prp4,Unclassified,O43172,PRPF4,PRP4_HUMAN,7.26,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,6.35,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.6,IC50,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,6.17,Kd,Tclin
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,cAMP-dependent protein kinase catalytic subunit alpha,Kinase,P17612,PRKACA,KAPCA_HUMAN,6.14,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,cAMP-dependent protein kinase catalytic subunit beta,Kinase,P22694,PRKACB,KAPCB_HUMAN,6.62,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,cGMP-dependent protein kinase 1,Kinase,Q13976,PRKG1,KGP1_HUMAN,6.6,Kd,Tchem
midostaurin,CO[C@@H]1[C@@H](C[C@H]2O[C@]1(C)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=CC=CC=C5N2C4=C13)N(C)C(=O)C1=CC=CC=C1,cGMP-dependent protein kinase 2,Kinase,Q13237,PRKG2,KGP2_HUMAN,7.13,Kd,Tchem
mifepristone,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1=CC=C(C=C1)N(C)C,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.33,Ki,Tclin
mifepristone,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1=CC=C(C=C1)N(C)C,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.64,Ki,Tclin
mifepristone,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1=CC=C(C=C1)N(C)C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9,IC50,Tclin
mifepristone,CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)C1=CC=C(C=C1)N(C)C,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,8.74,Ki,Tclin
migalastat,OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O,Alpha-galactosidase A,Enzyme,P06280,GLA,AGAL_HUMAN,7.150000095,IC50,Tclin
miglustat,CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO,Non-lysosomal glucosylceramidase,Enzyme,Q9HCG7,GBA2,GBA2_HUMAN,6.64,IC50,Tchem
milrinone,CC1=C(C=C(C#N)C(=O)N1)C1=CC=NC=C1,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,6.36,IC50,Tclin
minoxidil,NC1=CC(=NC(N)=[N+]1[O-])N1CCCCC1,ATP-sensitive inward rectifier potassium channel 1,Ion channel,P48048,KCNJ1,KCNJ1_HUMAN,6.97,IC50,Tchem
mitotane,ClC(Cl)C(C1=CC=C(Cl)C=C1)C1=C(Cl)C=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.099632871,Ki,Tclin
moexipril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC(OC)=C(OC)C=C2C[C@H]1C(O)=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.59,IC50,Tclin
molindone,CCC1=C(C)NC2=C1C(=O)C(CN1CCOCC1)CC2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.9066,Ki,Tclin
mometasone furoate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C1=CC=CO1)C(=O)CCl,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.9,EC50,Tclin
mosapride,CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.15490196,IC50,Tclin
mosapride,CCOC1=C(C=C(Cl)C(N)=C1)C(=O)NCC1CN(CC2=CC=C(F)C=C2)CCO1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.891434976,Ki,Tclin
mycophenolate mofetil,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1C\C=C(/C)CCC(=O)OCCN1CCOCC1,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,P20839,IMPDH1,IMDH1_HUMAN,7.481485844,Ki,Tclin
mycophenolic acid,COC1=C(C\C=C(/C)CCC(O)=O)C(O)=C2C(=O)OCC2=C1C,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,P20839,IMPDH1,IMDH1_HUMAN,7.48,Ki,Tclin
nafamostat,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,Plasminogen,Enzyme,P00747,PLG,PLMN_HUMAN,6.62,IC50,Tclin
nafamostat,NC(=N)NC1=CC=C(C=C1)C(=O)OC1=CC=C2C=C(C=CC2=C1)C(N)=N,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.54,IC50,Tclin
nafarelin,CC(C)C[C@H](NC(=O)[C@@H](CC1=CC2=C(C=CC=C2)C=C1)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,9.699,Kd,Tclin
naftifine,CN(C\C=C\C1=CC=CC=C1)CC1=CC=CC2=CC=CC=C12,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.06,Ki,Tclin
nalorphine,O[C@H]1C=C[C@H]2[C@H]3CC4=CC=C(O)C5=C4[C@@]2(CCN3CC=C)[C@H]1O5,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.32,IC50,Tclin
nandrolone phenpropionate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2OC(=O)CCC1=CC=CC=C1,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.5,EC50,Tclin
nandrolone phenpropionate,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2OC(=O)CCC1=CC=CC=C1,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.7,EC50,Tclin
nedocromil,CCCC1=C2N(CC)C(=CC(=O)C2=CC2=C1OC(=CC2=O)C(O)=O)C(O)=O,G-protein coupled receptor 35,GPCR,Q9HC97,GPR35,GPR35_HUMAN,6.013228416,EC50,Tchem
nefazodone,CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.4437,Kd,Tclin
nefopam,CN1CCOC(C2=CC=CC=C2)C2=CC=CC=C2C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.274905479,Ki,Tclin
nepinalone,CC1(CCN2CCCCC2)C(=O)CCC2=CC=CC=C12,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.522878647,Ki,Tclin
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,7.85,Kd,Tclin
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,7.59,Kd,Tclin
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,7.02,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,6.17,Kd,Tclin
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.85,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,7.229147911,IC50,Tclin
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,8.11,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,6.57,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,6.07,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,6.09,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,6.6,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Serine/threonine-protein kinase PAK 1,Kinase,Q13153,PAK1,PAK1_HUMAN,6.68,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,6.66,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,6.8,Kd,Tclin
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,6.4,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6.41,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.72,Kd,Tchem
neratinib,CCOC1=CC2=NC=C(C#N)C(NC3=CC=C(OCC4=CC=CC=N4)C(Cl)=C3)=C2C=C1NC(=O)\C=C\CN(C)C,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.07,IC50,Tclin
nicardipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.3768,IC50,Tclin
niclosamide,OC1=C(C=C(Cl)C=C1)C(=O)NC1=C(Cl)C=C(C=C1)[N+]([O-])=O,Signal transducer and activator of transcription 3,Transcription factor,P40763,STAT3,STAT3_HUMAN,6.6,IC50,Tchem
nicotine,CN1CCC[C@H]1C1=CC=CN=C1,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,P32297,CHRNA3,ACHA3_HUMAN,7.349999905,IC50,Tclin
nifedipine,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,9.4,Kd,Tclin
nifedipine,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,7.7,IC50,Tclin
nifedipine,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OC,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,Q13698,CACNA1S,CAC1S_HUMAN,6.3,IC50,Tclin
niflumic acid,OC(=O)C1=C(NC2=CC(=CC=C2)C(F)(F)F)N=CC=C1,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,6.59,Kd,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,6.31,Kd,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.39,Ki,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.35,Ki,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,8.22,Kd,Tchem
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,6.19,Kd,Tchem
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,6.14,Kd,Tchem
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.35,Kd,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.77,Kd,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.8,Kd,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.06,Kd,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,6.24,Kd,Tclin
nilotinib,CC1=CN(C=N1)C1=CC(=CC(NC(=O)C2=CC(NC3=NC=CC(=N3)C3=CN=CC=C3)=C(C)C=C2)=C1)C(F)(F)F,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.44,Kd,Tclin
nilutamide,CC1(C)NC(=O)N(C1=O)C1=CC(=C(C=C1)[N+]([O-])=O)C(F)(F)F,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.05,IC50,Tclin
nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.12,Ki,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.22,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.72,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,7.72,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,7.38,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,8,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,7.38,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,7.42021656,IC50,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.46,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,7.03,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.7,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,8.35,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,7.62,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,7.21,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,7.43,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.32,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.57,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,8.39,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,O15146,MUSK,MUSK_HUMAN,6.23,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.54,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,7.68,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,6.59,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.82,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.24,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.02,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,6.36,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,7.19,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,8.05,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,6.68,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,7.28,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Serine/threonine-protein kinase SIK1,Kinase,P57059,SIK1,SIK1_HUMAN,6.17,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Serine/threonine-protein kinase STK11,Kinase,Q15831,STK11,STK11_HUMAN,7.74,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,6.51,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,8.09,Kd,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,8.07,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,7.92,Kd,Tchem
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,6.982966423,IC50,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,8.301030159,IC50,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,8.301030159,IC50,Tclin
nintedanib,COC(=O)C1=CC2=C(C=C1)\C(=C(\NC1=CC=C(C=C1)N(C)C(=O)CN1CCN(C)CC1)C1=CC=CC=C1)C(=O)N2,cGMP-dependent protein kinase 1,Kinase,Q13976,PRKG1,KGP1_HUMAN,7.85,Kd,Tchem
nisoldipine,COC(=O)C1=C(C)NC(C)=C(C1C1=C(C=CC=C1)[N+]([O-])=O)C(=O)OCC(C)C,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,Q13936,CACNA1C,CAC1C_HUMAN,7.1,IC50,Tclin
nitrendipine,CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,Q01668,CACNA1D,CAC1D_HUMAN,8.4,IC50,Tclin
nomifensine,CN1CC(C2=CC=CC=C2)C2=CC=CC(N)=C2C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.31,Ki,Tclin
nordazepam,ClC1=CC=C2NC(=O)CN=C(C3=CC=CC=C3)C2=C1,Gamma-aminobutyric acid type B receptor subunit 2,GPCR,O75899,GABBR2,GABR2_HUMAN,8.027,IC50,Tclin
norethindrone acetate,CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.12,IC50,Tclin
norethindrone acetate,CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.64,Ki,Tclin
norethindrone acetate,CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.53313238,Ki,Tclin
norethindrone acetate,CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,11.2596,ED50,Tclin
norethisterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.12,IC50,Tclin
norethisterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.63638802,Ki,Tclin
norethisterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.705533774,Ki,Tclin
norethisterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,11.2596,ED50,Tclin
norfloxacin,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,6.29,IC50,Tclin
norfloxacin,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,6.29,IC50,Tclin
norfloxacin,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,6.29,IC50,Tclin
norfloxacin,CCN1C=C(C(O)=O)C(=O)C2=CC(F)=C(C=C12)N1CCNCC1,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,P31644,GABRA5,GBRA5_HUMAN,6.29,IC50,Tclin
nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.301,Ki,Tclin
olanzapine,CN1CCN(CC1)C1=NC2=CC=CC=C2NC2=C1C=C(C)S2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.136,Ki,Tclin
olmesartan medoxomil,CCCC1=NC(=C(N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C1=NN=NN1)C(=O)OCC1=C(C)OC(=O)O1)C(C)(C)O,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,8.1,IC50,Tclin
omapatrilat,OC(=O)[C@@H]1CCC[C@@H]2SCC[C@H](NC(=O)[C@@H](S)CC3=CC=CC=C3)C(=O)N12,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.22,Ki,Tclin
omapatrilat,OC(=O)[C@@H]1CCC[C@@H]2SCC[C@H](NC(=O)[C@@H](S)CC3=CC=CC=C3)C(=O)N12,Neprilysin,Enzyme,P08473,MME,NEP_HUMAN,8.05,Ki,Tclin
opicapone,CC1=C(C2=NOC(=N2)C2=CC(O)=C(O)C(=C2)[N+]([O-])=O)C(Cl)=[N+]([O-])C(C)=C1Cl,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,9,Ki,Tclin
opipramol,OCCN1CCN(CCCN2C3=CC=CC=C3C=CC3=C2C=CC=C3)CC1,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.89,Ki,Tchem
opipramol,OCCN1CCN(CCCN2C3=CC=CC=C3C=CC3=C2C=CC=C3)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,9.7,Ki,Tclin
orlistat,CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,Monoacylglycerol lipase ABHD12,Enzyme,Q8N2K0,ABHD12,ABD12_HUMAN,7.1,IC50,Tchem
orphenadrine,CN(C)CCOC(C1=CC=CC=C1)C1=C(C)C=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.431798276,Ki,Tclin
osilodrostat,FC1=C(C=CC(=C1)C#N)[C@H]1CCC2=CN=CN12,"Cytochrome P450 11B1, mitochondrial",Enzyme,P15538,CYP11B1,C11B1_HUMAN,8.6,IC50,Tclin
osimertinib,COC1=C(NC2=NC=CC(=N2)C2=CN(C)C3=C2C=CC=C3)C=C(NC(=O)C=C)C(=C1)N(C)CCN(C)C,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,6.039999962,IC50,Tclin
ospemifene,OCCOC1=CC=C(C=C1)C(=C(\CCCl)C1=CC=CC=C1)\C1=CC=CC=C1,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.0824943,IC50,Tclin
oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.045757491,IC50,Tclin
oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.017547849,Ki,Tclin
oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=C1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.209433375,IC50,Tchem
oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.11,Ki,Tclin
oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.991399828,Ki,Tclin
oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.168130226,Ki,Tclin
ozagrel,OC(=O)\C=C\C1=CC=C(CN2C=CN=C2)C=C1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,7.96,IC50,Tchem
paclitaxel,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,Tubulin beta chain,Structural,P07437,TUBB,TBB5_HUMAN,8.05,EC50,Tclin
paclitaxel,CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)C3=CC=CC=C3)[C@@H]3[C@@]4(CO[C@@H]4C[C@H](O)[C@@]3(C)C1=O)OC(C)=O)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C1=CC=CC=C1)C1=CC=CC=C1,Tubulin beta-3 chain,Structural,Q13509,TUBB3,TBB3_HUMAN,8.109999657,IC50,Tclin
palbociclib,CC(=O)C1=C(C)C2=C(N=C(NC3=NC=C(C=C3)N3CCNCC3)N=C2)N(C2CCCC2)C1=O,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,7.2,IC50,Tclin
panobinostat,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,Histone deacetylase 4,Enzyme,P56524,HDAC4,HDAC4_HUMAN,9.22,Ki,Tclin
panobinostat,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,9.15,Ki,Tclin
panobinostat,CC1=C(CCNCC2=CC=C(\C=C\C(=O)NO)C=C2)C2=CC=CC=C2N1,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,7.66,Ki,Tclin
papaverine,COC1=C(OC)C=C(CC2=NC=CC3=CC(OC)=C(OC)C=C23)C=C1,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,Q14432,PDE3A,PDE3A_HUMAN,6.55,Ki,Tclin
paraoxon,CCOP(=O)(OCC)OC1=CC=C(C=C1)[N+]([O-])=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.23,IC50,Tclin
paricalcitol,C[C@H](\C=C\[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1C[C@@H](O)C[C@H](O)C1,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,8.7,EC50,Tclin
paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.420216403,Ki,Tclin
paroxetine,FC1=CC=C(C=C1)[C@@H]1CCNC[C@H]1COC1=CC2=C(OCO2)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.3098,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.12,Kd,Tchem
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,7.01,Kd,Tchem
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.68,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.21,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,LIM domain kinase 1,Kinase,P53667,LIMK1,LIMK1_HUMAN,6.14,Kd,Tchem
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,8.1,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.74,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,8.7,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.57,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,6.05,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Serine/threonine-protein kinase 36,Kinase,Q9NRP7,STK36,STK36_HUMAN,6.33,Kd,Tbio
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,6.37,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,6.01,Kd,Tchem
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.54,Kd,Tchem
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,6.62,Kd,Tbio
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.42,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,6.15,Kd,Tchem
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,7.85,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,7.85,Kd,Tclin
pazopanib,CN(C1=CC2=NN(C)C(C)=C2C=C1)C1=NC(NC2=CC(=C(C)C=C2)S(N)(=O)=O)=NC=C1,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,7.57,Kd,Tclin
pecazine,CN1CCCC(CN2C3=CC=CC=C3SC3=CC=CC=C23)C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.397940009,Ki,Tclin
pecazine,CN1CCCC(CN2C3=CC=CC=C3SC3=CC=CC=C23)C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.119186408,Ki,Tclin
pemigatinib,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,9.4,IC50,Tclin
pemigatinib,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,9.3,IC50,Tclin
pemigatinib,CCN1C(=O)N(CC2=CN=C3NC(CN4CCOCC4)=CC3=C12)C1=C(F)C(OC)=CC(OC)=C1F,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,9,IC50,Tclin
pemoline,NC1=NC(=O)C(O1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.382789905,Ki,Tclin
pentazocine,CC1C2CC3=CC=C(O)C=C3C1(C)CCN2CC=C(C)C,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.76,EC50,Tclin
pentostatin,OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1NC=NC[C@H]2O,Adenosine deaminase,Enzyme,P00813,ADA,ADA_HUMAN,10.8,IC50,Tclin
pentoxyverine,CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.71,Ki,Tclin
perhexiline,C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.179798541,Ki,Tclin
perindopril,CCC[C@H](N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(O)=O)C(=O)OCC,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.82,IC50,Tclin
pexidartinib,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.88,IC50,Tclin
pexidartinib,FC(F)(F)C1=CC=C(CNC2=NC=C(CC3=CNC4=NC=C(Cl)C=C34)C=C2)C=N1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.56,IC50,Tclin
phenmetrazine,CC1NCCOC1C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.8827,EC50,Tclin
phentolamine,CC1=CC=C(C=C1)N(CC1=NCCN1)C1=CC(O)=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.26,IC50,Tclin
phenylpropanolamine,CC(N)C(O)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.165579296,Ki,Tclin
pilocarpine,CC[C@H]1[C@@H](CC2=CN=CN2C)COC1=O,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.96999979,EC50,Tclin
pimozide,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.8416,Ki,Tclin
pimozide,FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=C1C=CC=C2)C1=CC=C(F)C=C1,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,O43497,CACNA1G,CAC1G_HUMAN,7.4,Kd,Tclin
pioglitazone,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.943095149,IC50,Tclin
pioglitazone,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)N=C1,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,6.23,EC50,Tclin
pipamazine,NC(=O)C1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C23)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.318758763,Ki,Tclin
pirenzepine,CN1CCN(CC(=O)N2C3=CC=CC=C3C(=O)NC3=C2N=CC=C3)CC1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.61,Ki,Tclin
plerixafor,C(N1CCCNCCNCCCNCC1)C1=CC=C(CN2CCCNCCNCCCNCC2)C=C1,C-X-C chemokine receptor type 4,GPCR,P61073,CXCR4,CXCR4_HUMAN,6.05,Ki,Tclin
podophyllotoxin,COC1=CC(=CC(OC)=C1OC)[C@H]1[C@@H]2[C@H](COC2=O)[C@@H](O)C2=CC3=C(OCO3)C=C12,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22184875,IC50,Tclin
podophyllotoxin,COC1=CC(=CC(OC)=C1OC)[C@H]1[C@@H]2[C@H](COC2=O)[C@@H](O)C2=CC3=C(OCO3)C=C12,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.85,IC50,Tclin
ponatinib,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,Cyclin-dependent kinase 19,Kinase,Q9BWU1,CDK19,CDK19_HUMAN,7.92,Kd,Tchem
ponatinib,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,Cyclin-dependent kinase 8,Kinase,P49336,CDK8,CDK8_HUMAN,8.17,Kd,Tchem
ponatinib,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,8.657577515,IC50,Tclin
ponatinib,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.90309,IC50,Tclin
ponatinib,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,8.520000458,IC50,Tclin
ponatinib,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.590000153,IC50,Tclin
ponatinib,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,9.431797981,IC50,Tclin
ponatinib,CN1CCN(CC2=CC=C(NC(=O)C3=CC=C(C)C(=C3)C#CC3=CN=C4C=CC=NN34)C=C2C(F)(F)F)CC1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,8.823908806,IC50,Tclin
pramocaine,CCCCOC1=CC=C(OCCCN2CCOCC2)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.292429824,Ki,Tclin
prednisolone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.8,EC50,Tclin
prednisolone,C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,Glutamine synthetase,Enzyme,P15104,GLUL,GLNA_HUMAN,7.49,EC50,Tchem
prednisolone tebutate,CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.28,IC50,Tclin
prednisolone tebutate,CC(C)(C)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C,Glutamine synthetase,Enzyme,P15104,GLUL,GLNA_HUMAN,7.5,EC50,Tchem
prednisone,C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,8,EC50,Tclin
pridinol,OC(CCN1CCCCC1)(C1=CC=CC=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.19382,Ki,Tclin
probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.369999886,Ki,Tclin
prochlorperazine,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.493494968,Ki,Tclin
prochlorperazine,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(Cl)C=C3)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.638272164,Ki,Tclin
procyclidine,OC(CCN1CCCC1)(C1CCCCC1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.906578541,Ki,Tclin
progesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,8.07,Ki,Tclin
progesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Cation channel sperm-associated protein 1,Ion channel,Q8NEC5,CATSPER1,CTSR1_HUMAN,8.11,EC50,Tchem
progesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Cation channel sperm-associated protein 2,Ion channel,Q96P56,CATSPER2,CTSR2_HUMAN,8.11,EC50,Tchem
progesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.52,Ki,Tclin
progesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.8761,ED50,Tclin
progesterone,CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.59,Ki,Tclin
promazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.055517328,Ki,Tclin
promazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=CC=C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.943095149,Ki,Tclin
promegestone,CCC(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@]12C,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.4,Kd,Tclin
promethazine,CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.381951903,Ki,Tclin
promethazine,CC(CN1C2=CC=CC=C2SC2=C1C=CC=C2)N(C)C,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.920818754,Ki,Tclin
propantheline,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC2=C1C=CC=C2)C(C)C,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,10,Ki,Tclin
proparacaine,CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7,Ki,Tclin
protriptyline,CNCCCC1C2=CC=CC=C2C=CC2=C1C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7,Ki,Tclin
pyrazinamide,NC(=O)C1=NC=CN=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.89,IC50,Tclin
pyrovalerone,CCCC(N1CCCC1)C(=O)C1=CC=C(C)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,8.1,Ki,Tclin
quercetin,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,7.92,IC50,Tclin
quercetin,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,Hepatocyte growth factor receptor,Kinase,P08581,MET,MET_HUMAN,6.24,IC50,Tclin
quercetin,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,6.52,IC50,Tclin
quercetin,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,7.41,Kd,Tclin
quercetin,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.92,IC50,Tclin
quercetin,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.02,IC50,Tchem
quercetin,OC1=CC(O)=C2C(OC(=C(O)C2=O)C2=CC(O)=C(O)C=C2)=C1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.55,IC50,Tclin
quetiapine,OCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.01596802,Ki,Tclin
quinapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2=CC=CC=C2C[C@H]1C(O)=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.08,IC50,Tclin
racecadotril,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,6.5,IC50,Tclin
racecadotril,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1,Endothelin-converting enzyme 1,Unclassified,P42892,ECE1,ECE1_HUMAN,8.1,IC50,(null)
racecadotril,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC1=CC=CC=C1,Neprilysin,Enzyme,P08473,MME,NEP_HUMAN,9,IC50,Tclin
radotinib,CC1=CN(C=N1)C1=CC(NC(=O)C2=CC=C(C)C(NC3=NC=CC(=N3)C3=CN=CC=N3)=C2)=CC(=C1)C(F)(F)F,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,7.514278412,IC50,Tclin
raloxifene,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,9,Ki,Tchem
raloxifene,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,9.4,IC50,Tclin
raloxifene,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,Estrogen receptor beta,Nuclear hormone receptor,Q92731,ESR2,ESR2_HUMAN,8,EC50,Tclin
raloxifene,OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.42,Ki,Tclin
raltegravir,CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1,C-C chemokine receptor type 1,GPCR,P32246,CCR1,CCR1_HUMAN,8.3,Ki,Tchem
ramipril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1[C@H]2CCC[C@H]2C[C@H]1C(O)=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.3418,Ki,Tclin
ramucirumab,(null),Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,10.3,Kd,Tclin
reboxetine,CCOC1=C(O[C@@H]([C@H]2CNCCO2)C2=CC=CC=C2)C=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.22,Ki,Tclin
regorafenib,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,7.55,IC50,Tclin
regorafenib,CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=CC=N1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,7.9,IC50,Tclin
remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,Renin,Enzyme,P00797,REN,RENI_HUMAN,9.154901505,IC50,Tclin
remoxipride,CCN1CCC[C@H]1CNC(=O)C1=C(OC)C(Br)=CC=C1OC,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.26,Ki,Tclin
repaglinide,CCOC1=C(C=CC(CC(=O)N[C@@H](CC(C)C)C2=C(C=CC=C2)N2CCCCC2)=C1)C(O)=O,ATP-binding cassette sub-family C member 8,Ion channel,Q09428,ABCC8,ABCC8_HUMAN,7.300000191,Kd,Tclin
reserpine,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C(NC5=C4C=CC(OC)=C5)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)C1=CC(OC)=C(OC)C(OC)=C1,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,7.9,Ki,Tclin
retinol,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,Retinol-binding protein 4,Secreted,P02753,RBP4,RET4_HUMAN,6.74,Kd,Tchem
retinol acetate,CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,Retinol-binding protein 4,Secreted,P02753,RBP4,RET4_HUMAN,6.739999771,Kd,Tchem
revefenacin,CN(CCN1CCC(CC1)OC(=O)NC1=C(C=CC=C1)C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.75,Ki,Tclin
ridaforolimus,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1OP(C)(C)=O,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,9.698969841,IC50,Tclin
rilonacept,(null),Interleukin-1 receptor antagonist protein,Unclassified,P18510,IL1RN,IL1RA_HUMAN,11.21467018,Kd,Tchem
risperidone,CC1=C(CCN2CCC(CC2)C2=NOC3=C2C=CC(F)=C3)C(=O)N2CCCCC2=N1,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.489999771,EC50,Tclin
ritonavir,CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.55,IC50,Tclin
ritonavir,CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,7.119186408,IC50,Tchem
rivaroxaban,ClC1=CC=C(S1)C(=O)NC[C@H]1CN(C(=O)O1)C1=CC=C(C=C1)N1CCOCC1=O,Coagulation factor X,Enzyme,P00742,F10,FA10_HUMAN,9.4,Ki,Tclin
roflumilast,FC(F)OC1=C(OCC2CC2)C=C(C=C1)C(=O)NC1=C(Cl)C=NC=C1Cl,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,Q08499,PDE4D,PDE4D_HUMAN,9.57,IC50,Tclin
romidepsin,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,Histone deacetylase 4,Enzyme,P56524,HDAC4,HDAC4_HUMAN,6.2924,IC50,Tclin
romidepsin,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,6.5227,Ki,Tclin
romidepsin,C\C=C1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,9.82,Ki,Tclin
romosozumab,(null),Sclerostin,Glycoprotein,Q9BQB4,SOST,SOST_HUMAN,11.7,Kd,Tclin
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,7.04,EC50,Tclin
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,6.6,Kd,Tchem
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,6.42,Kd,Tclin
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.54,Kd,Tchem
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,Myotonin-protein kinase,Kinase,Q09013,DMPK,DMPK_HUMAN,6.55,Kd,Tchem
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.49,Kd,Tchem
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,Protein kinase C delta type,Kinase,Q05655,PRKCD,KPCD_HUMAN,8.44,Kd,Tclin
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,Protein kinase C gamma type,Kinase,P05129,PRKCG,KPCG_HUMAN,6.52,IC50,Tchem
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,6.66,Kd,Tchem
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.43,Kd,Tchem
ruboxistaurin,CN(C)C[C@@H]1CCN2C=C(C3=CC=CC=C23)C2=C(C(=O)NC2=O)C2=CN(CCO1)C1=CC=CC=C21,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,6.38,Kd,Tclin
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,6.44,Kd,Tclin
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,Q13555,CAMK2G,KCC2G_HUMAN,7,Kd,Tchem
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,6.04,Kd,Tchem
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,7.05,Kd,Tchem
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,6.14,Kd,Tchem
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,6.44,Kd,Tchem
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.49,Kd,Tchem
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,6.72,Kd,Tclin
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.7,Kd,Tchem
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,8.7,Kd,Tclin
ruxolitinib,N#CC[C@H](C1CCCC1)N1C=C(C=N1)C1=C2C=CNC2=NC=N1,cGMP-dependent protein kinase 2,Kinase,Q13237,PRKG2,KGP2_HUMAN,6.16,Kd,Tchem
sabcomeline,CO\N=C(/C#N)[C@H]1CN2CCC1CC2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.22,IC50,Tclin
saralasin,CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.77,Ki,Tclin
saralasin,CNCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O,Type-2 angiotensin II receptor,GPCR,P50052,AGTR2,AGTR2_HUMAN,9.82,Ki,Tchem
saroglitazar,CCO[C@@H](CC1=CC=C(OCCN2C(C)=CC=C2C2=CC=C(SC)C=C2)C=C1)C(O)=O,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,8.522878647,EC50,Tclin
saxagliptin,N[C@H](C(=O)N1[C@H]2C[C@H]2C[C@H]1C#N)C12CC3CC(CC(O)(C3)C1)C2,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,7.15,Ki,Tchem
scopolamine,CN1[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,9.4,Ki,Tclin
selumetinib,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3Cl)=C(C=C12)C(=O)NOCCO,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,7.85,IC50,Tclin
selumetinib,CN1C=NC2=C(F)C(NC3=CC=C(Br)C=C3Cl)=C(C=C12)C(=O)NOCCO,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,7.85,IC50,Tclin
seractide,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,Adrenocorticotropic hormone receptor,GPCR,Q01718,MC2R,ACTHR_HUMAN,8.008773804,Ki,Tclin
sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.24,Ki,Tclin
sertraline,CN[C@H]1CC[C@@H](C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C12,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,7.6,Kd,Tclin
sibutramine,CC(C)CC(N(C)C)C1(CCC1)C1=CC=C(Cl)C=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.0255,Ki,Tclin
sirolimus,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N3CCCC[C@H]3C(=O)O2)OC)CC[C@H]1O,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,10,IC50,Tclin
sitaxentan,CC1=NOC(NS(=O)(=O)C2=C(SC=C2)C(=O)CC2=CC3=C(OCO3)C=C2C)=C1Cl,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,9.37,Ki,Tclin
sivelestat,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC1=C(C=CC=C1)C(=O)NCC(O)=O,Myeloblastin,Unclassified,P24158,PRTN3,PRTN3_HUMAN,6.46999979,IC50,Tchem
sodium citrate,(null),Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,7,Ki,Tclin
solifenacin,O=C(O[C@H]1CN2CCC1CC2)N1CCC2=CC=CC=C2[C@@H]1C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.88,IC50,Tclin
sonidegib,C[C@H]1CN(C[C@@H](C)O1)C1=NC=C(NC(=O)C2=CC=CC(=C2C)C2=CC=C(OC(F)(F)F)C=C2)C=C1,Smoothened homolog,GPCR,Q99835,SMO,SMO_HUMAN,8.221848488,Ki,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.68,Kd,Tchem
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Cyclin-dependent kinase 19,Kinase,Q9BWU1,CDK19,CDK19_HUMAN,6.6,Kd,Tchem
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Cyclin-dependent kinase 8,Kinase,P49336,CDK8,CDK8_HUMAN,6.51,Kd,Tchem
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,8.18,Kd,Tchem
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,7.55,Kd,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.8,Kd,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.96,IC50,Tchem
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,6.16,Kd,Tchem
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,O15146,MUSK,MUSK_HUMAN,6.89,Kd,Tchem
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.43,Kd,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.41,IC50,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.13,Kd,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,8.22,Ki,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,7.66,Ki,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,6.27,Kd,Tbio
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,6.89,Kd,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Tyrosine-protein kinase receptor Tie-1,Kinase,P35590,TIE1,TIE1_HUMAN,7.17,Kd,Tchem
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,7.51,Kd,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,10.68,Ki,Tclin
sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,7.8,Kd,Tclin
spiperone,FC1=CC=C(C=C1)C(=O)CCCN1CCC2(CC1)N(CNC2=O)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.02,IC50,Tclin
spirapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(O)=O)SCCS2,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,9.1,IC50,Tclin
spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,7.4,Ki,Tclin
spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,6.2272,IC50,Tclin
spironolactone,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]33CCC(=O)O3)[C@H]12,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.0286,EC50,Tclin
stallimycin,CN1C=C(NC(=O)C2=CC(NC(=O)C3=CC(NC=O)=CN3C)=CN2C)C=C1C(=O)NCCC(N)=N,GTPase HRas,Cytosolic other,P01112,HRAS,RASH_HUMAN,6.7,IC50,Tchem
stanozolol,C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC5=C(C[C@]4(C)[C@H]3CC[C@]12C)C=NN5,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,7.494850022,Ki,Tclin
sulconazole,ClC1=CC=C(CS[C@@H](CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,7.15490196,IC50,Tclin
sulconazole,ClC1=CC=C(CS[C@@H](CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.142064735,Ki,Tclin
sulconazole,ClC1=CC=C(CS[C@@H](CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.73754891,IC50,Tchem
sulfafurazole,CC1=NOC(NS(=O)(=O)C2=CC=C(N)C=C2)=C1C,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,6.11,IC50,Tclin
sulfaguanidine,NC(=N)NS(=O)(=O)C1=CC=C(N)C=C1,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,7.02,Ki,Tclin
sulfanilamide,NC1=CC=C(C=C1)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.62,Ki,Tclin
sulfisoxazole acetyl,CC(=O)N(C1=C(C)C(C)=NO1)S(=O)(=O)C1=CC=C(N)C=C1,Endothelin-1 receptor,GPCR,P25101,EDNRA,EDNRA_HUMAN,6.11,IC50,Tclin
sulindac,CC1=C(CC(O)=O)C2=C(C=CC(F)=C2)\C1=C/C1=CC=C(C=C1)S(C)=O,Glycine receptor subunit alpha-1,Ion channel,P23415,GLRA1,GLRA1_HUMAN,6.420000076,EC50,Tclin
suloctidil,CCCCCCCCNC(C)C(O)C1=CC=C(SC(C)C)C=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.008773924,Ki,Tclin
suloctidil,CCCCCCCCNC(C)C(O)C1=CC=C(SC(C)C)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.307153081,Ki,Tclin
sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.3979,IC50,Tclin
sultiame,NS(=O)(=O)C1=CC=C(C=C1)N1CCCCS1(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.05,Ki,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Aurora kinase C,Kinase,Q9UQB9,AURKC,AURKC_HUMAN,6.66,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,BDNF/NT-3 growth factors receptor,Kinase,Q16620,NTRK2,NTRK2_HUMAN,6.23,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,Q13555,CAMK2G,KCC2G_HUMAN,6.36,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Casein kinase II subunit alpha,Kinase,P68400,CSNK2A1,CSK21_HUMAN,7.09,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,6.89,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,6.96,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,Q13627,DYRK1A,DYR1A_HUMAN,6.7,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,Q9P2K8,EIF2AK4,E2AK4_HUMAN,6.74,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6.28,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Fibroblast growth factor receptor 2,Kinase,P21802,FGFR2,FGFR2_HUMAN,6.28,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.54,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,High affinity nerve growth factor receptor,Kinase,P04629,NTRK1,NTRK1_HUMAN,7,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Kinase,O15111,CHUK,IKKA_HUMAN,6.28,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Insulin receptor,Kinase,P06213,INSR,INSR_HUMAN,6.74,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,7.12,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Macrophage colony-stimulating factor 1 receptor,Kinase,P07333,CSF1R,CSF1R_HUMAN,8.7,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,9.68,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Mitogen-activated protein kinase kinase kinase 7,Kinase,O43318,MAP3K7,M3K7_HUMAN,7.03,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,O15146,MUSK,MUSK_HUMAN,6.31,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,"Myosin light chain kinase, smooth muscle",Kinase,Q15746,MYLK,MYLK_HUMAN,7.64,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.82,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,P15735,PHKG2,PHKG2_HUMAN,8.23,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,10.12,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Protein delta homolog 1,Unclassified,P80370,DLK1,DLK1_HUMAN,7,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,8.8,IC50,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Ribosomal protein S6 kinase alpha-3,Kinase,P51812,RPS6KA3,KS6A3_HUMAN,7.26,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase 4,Kinase,Q13043,STK4,STK4_HUMAN,7.72,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase Chk2,Kinase,O96017,CHEK2,CHK2_HUMAN,8.15,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase D1,Kinase,Q15139,PRKD1,KPCD1_HUMAN,6.51,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase Nek2,Kinase,P51955,NEK2,NEK2_HUMAN,6.3,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase PAK 3,Kinase,O75914,PAK3,PAK3_HUMAN,7.8,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.72,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase STK11,Kinase,Q15831,STK11,STK11_HUMAN,7.42,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase TAO1,Kinase,Q7L7X3,TAOK1,TAOK1_HUMAN,6.05,Kd,Tbio
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Serine/threonine-protein kinase tousled-like 2,Kinase,Q86UE8,TLK2,TLK2_HUMAN,6.48,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,7.26,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Tyrosine-protein kinase Mer,Kinase,Q12866,MERTK,MERTK_HUMAN,7.59,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,8.05,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,U4/U6 small nuclear ribonucleoprotein Prp4,Unclassified,O43172,PRPF4,PRP4_HUMAN,6.41,Kd,Tchem
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,7.229147911,IC50,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,9.7,Kd,Tclin
sunitinib,CCN(CC)CCNC(=O)C1=C(C)NC(\C=C2/C(=O)NC3=C2C=C(F)C=C3)=C1C,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,7.77,Ki,Tclin
tacalcitol,CC(C)[C@H](O)CC[C@@H](C)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C,Vitamin D3 receptor,Nuclear hormone receptor,P11473,VDR,VDR_HUMAN,8.5,Kd,Tclin
tacrine,NC1=C2CCCCC2=NC2=CC=CC=C12,Acetylcholine receptor subunit epsilon,Ion channel,Q04844,CHRNE,ACHE_HUMAN,7.36,IC50,Tclin
tacrolimus,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@@H]1C)OC,Peptidyl-prolyl cis-trans isomerase FKBP10,Enzyme,Q96AY3,FKBP10,FKB10_HUMAN,9.02,IC50,Tbio
tacrolimus,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@@H]1C)OC,Serine/threonine-protein kinase mTOR,Kinase,P42345,MTOR,MTOR_HUMAN,9.02,IC50,Tclin
tacrolimus,CO[C@@H]1C[C@@H](CC[C@H]1O)\C=C(/C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@]2(O)O[C@@H]([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@@H]1C)OC,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,Enzyme,Q08209,PPP3CA,PP2BA_HUMAN,7.7,Kd,Tchem
tadalafil,CN1CC(=O)N2[C@H](CC3=C(NC4=C3C=CC=C4)[C@H]2C2=CC=C3OCOC3=C2)C1=O,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,7.48,IC50,Tchem
tafamidis,OC(=O)C1=CC2=C(C=C1)N=C(O2)C1=CC(Cl)=CC(Cl)=C1,Transthyretin,Secreted,P02766,TTR,TTHY_HUMAN,6.812,Kd,Tclin
tamibarotene,CC1(C)CCC(C)(C)C2=CC(NC(=O)C3=CC=C(C=C3)C(O)=O)=CC=C12,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,7.11,IC50,Tclin
tamibarotene,CC1(C)CCC(C)(C)C2=CC(NC(=O)C3=CC=C(C=C3)C(O)=O)=CC=C12,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,6.63,EC50,Tclin
tamoxifen,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,8.301,Ki,Tchem
tamoxifen,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,7.51,Ki,Tclin
tamoxifen,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,6.200659451,Ki,Tclin
tamoxifen,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,6.89,IC50,Tclin
tamoxifen,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.5,Ki,Tclin
tamoxifen,CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.038104526,IC50,Tchem
tannic acid,(null),Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.730000019,IC50,Tchem
tannic acid,(null),Thromboxane-A synthase,Enzyme,P24557,TBXAS1,THAS_HUMAN,6.489999771,IC50,Tchem
tasosartan,CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C=C3)C3=C(C=CC=C3)C3=NN=NN3)C2=N1,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,7.49,IC50,Tclin
tazarotene,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC=C2SCCC(C)(C)C2=C1,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,7.2,EC50,Tclin
tazarotene,CCOC(=O)C1=CN=C(C=C1)C#CC1=CC=C2SCCC(C)(C)C2=C1,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,9.1,EC50,Tclin
tazemetostat,CCN(C1CCOCC1)C1=CC(=CC(C(=O)NCC2=C(C)C=C(C)NC2=O)=C1C)C1=CC=C(CN2CCOCC2)C=C1,Histone-lysine N-methyltransferase EZH2,Enzyme,Q15910,EZH2,EZH2_HUMAN,7.96,IC50,Tclin
telaprevir,CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,Cathepsin B,Enzyme,P07858,CTSB,CATB_HUMAN,6.68,IC50,Tchem
telaprevir,CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)C1=CN=CC=N1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1,Cathepsin K,Enzyme,P43235,CTSK,CATK_HUMAN,6.2,IC50,Tchem
telmisartan,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O,Type-1 angiotensin II receptor,GPCR,P30556,AGTR1,AGTR1_HUMAN,9.31,IC50,Tclin
telmisartan,CCCC1=NC2=C(C=C(C=C2C)C2=NC3=C(C=CC=C3)N2C)N1CC1=CC=C(C=C1)C1=C(C=CC=C1)C(O)=O,Type-2 angiotensin II receptor,GPCR,P50052,AGTR2,AGTR2_HUMAN,9.48,IC50,Tchem
teneligliptin,CC1=NN(C(=C1)N1CCN(CC1)[C@@H]1CN[C@@H](C1)C(=O)N1CCSC1)C1=CC=CC=C1,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,6.267606258,IC50,Tchem
teprotumumab,(null),Insulin-like growth factor 1 receptor,Kinase,P08069,IGF1R,IGF1R_HUMAN,9,IC50,Tclin
terbinafine,CN(C\C=C\C#CC(C)(C)C)CC1=C2C=CC=CC2=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.628193541,Ki,Tclin
terconazole,CC(C)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=NC=N3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.669586227,Ki,Tclin
terfenadine,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,Potassium voltage-gated channel subfamily H member 1,Ion channel,O95259,KCNH1,KCNH1_HUMAN,7.8,IC50,Tclin
terfenadine,CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.692503962,Ki,Tclin
teriflunomide,C\C(O)=C(/C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,Q02127,DHODH,PYRD_HUMAN,7.52,Ki,Tclin
teriparatide,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O,Parathyroid hormone/parathyroid hormone-related peptide receptor,GPCR,Q03431,PTH1R,PTH1R_HUMAN,7.4,IC50,Tclin
testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.2,EC50,Tclin
testosterone,C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,6.22,Ki,Tclin
testosterone propionate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,Androgen receptor,Nuclear hormone receptor,P10275,AR,ANDR_HUMAN,9.6,Ki,Tclin
testosterone propionate,CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,7.25,IC50,Tclin
tetrabenazine,COC1=CC2=C(C=C1OC)[C@@H]1CC(=O)[C@@H](CC(C)C)CN1CC2,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,7,Ki,Tclin
tetracaine,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.153044675,Ki,Tclin
tetracaine,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,Sodium channel protein type 5 subunit alpha,Ion channel,Q14524,SCN5A,SCN5A_HUMAN,6.28,IC50,Tclin
tetracaine,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,Sodium channel protein type 9 subunit alpha,Ion channel,Q15858,SCN9A,SCN9A_HUMAN,6.3,Ki,Tclin
tetracosactide,CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(O)=O,Adrenocorticotropic hormone receptor,GPCR,Q01718,MC2R,ACTHR_HUMAN,8.267605782,Ki,Tclin
thiethylperazine,CCSC1=CC=C2SC3=CC=CC=C3N(CCCN3CCN(C)CC3)C2=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.1549,Ki,Tclin
thioridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.595220089,Ki,Tclin
thioridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.815308569,Ki,Tclin
thyropropic acid,OC(=O)CCC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,10.39,IC50,Tclin
tiagabine,CC1=C(SC=C1)C(=CCCN1CCC[C@H](C1)C(O)=O)C1=C(C)C=CS1,Sodium- and chloride-dependent GABA transporter 1,Transporter,P30531,SLC6A1,SC6A1_HUMAN,7.77,Ki,Tclin
tibolone,C[C@@H]1CC2=C(CCC(=O)C2)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]3(O)C#C)[C@H]12,Estrogen receptor,Nuclear hormone receptor,P03372,ESR1,ESR1_HUMAN,6.907279355,Ki,Tclin
ticlopidine,ClC1=C(CN2CCC3=C(C2)C=CS3)C=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.747146969,Ki,Tclin
tioconazole,ClC1=C(COC(CN2C=CN=C2)C2=C(Cl)C=C(Cl)C=C2)C=CS1,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,P05093,CYP17A1,CP17A_HUMAN,6.3,Ki,Tclin
tiotropium bromide,C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(C1=CC=CS1)C1=CC=CS1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,11.1,Ki,Tclin
tipiracil,ClC1=C(CN2CCCC2=N)NC(=O)NC1=O,Thymidine phosphorylase,Enzyme,P19971,TYMP,TYPH_HUMAN,7.698969841,IC50,Tclin
tiratricol,OC(=O)CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1,Thyroid hormone receptor alpha,Nuclear hormone receptor,P10827,THRA,THA_HUMAN,9.85,IC50,Tclin
tivozanib,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6.524329,IC50,Tclin
tivozanib,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,8.787812,IC50,Tclin
tivozanib,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,8.764472,IC50,Tclin
tivozanib,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,9.677781,IC50,Tclin
tivozanib,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,9.79588,IC50,Tclin
tivozanib,COC1=C(OC)C=C2C(OC3=CC=C(NC(=O)NC4=NOC(C)=C4)C(Cl)=C3)=CC=NC2=C1,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,9.619789,IC50,Tclin
tofacitinib,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,Q5S007,LRRK2,LRRK2_HUMAN,6.26,Kd,Tchem
tofacitinib,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,NUAK family SNF1-like kinase 2,Kinase,Q9H093,NUAK2,NUAK2_HUMAN,6.62,Kd,Tchem
tofacitinib,C[C@@H]1CCN(C[C@@H]1N(C)C1=C2C=CNC2=NC=N1)C(=O)CC#N,Tyrosine-protein kinase JAK3,Kinase,P52333,JAK3,JAK3_HUMAN,8.48148632,IC50,Tclin
tolcapone,CC1=CC=C(C=C1)C(=O)C1=CC(=C(O)C(O)=C1)[N+]([O-])=O,Catechol O-methyltransferase,Enzyme,P21964,COMT,COMT_HUMAN,9.568635941,Ki,Tclin
tolonium,CN(C)C1=CC2=[S+]C3=CC(N)=C(C)C=C3N=C2C=C1,Microtubule-associated protein tau,Structural,P10636,MAPT,TAU_HUMAN,7.16,Ki,Tchem
tolperisone,CC(CN1CCCCC1)C(=O)C1=CC=C(C)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.252588192,Ki,Tclin
tolterodine,CC(C)N(CC[C@H](C1=CC=CC=C1)C1=C(O)C=CC(C)=C1)C(C)C,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.49,Ki,Tclin
topiramate,CC1(C)O[C@@H]2CO[C@@]3(COS(N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,8.3,Ki,Tclin
trabectedin,COC1=CC2=C(CCN[C@]22CS[C@H]3[C@H]4[C@@H]5N(C)[C@@H](CC6=C5C(O)=C(OC)C(C)=C6)[C@H](O)N4[C@@H](COC2=O)C2=C3C(OC(C)=O)=C(C)C3=C2OCO3)C=C1O,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,6.68,IC50,Tclin
trametinib,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=C(F)C=C(I)C=C1)C1=CC(NC(C)=O)=CC=C1,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,Q02750,MAP2K1,MP2K1_HUMAN,8.744727,IC50,Tclin
trametinib,CN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=C(F)C=C(I)C=C1)C1=CC(NC(C)=O)=CC=C1,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,P36507,MAP2K2,MP2K2_HUMAN,9.036212,IC50,Tclin
trandolapril,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@@H]2C[C@H]1C(O)=O,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,8.12,IC50,Tclin
trastuzumab deruxtecan,(null),Receptor tyrosine-protein kinase erbB-2,Kinase,P04626,ERBB2,ERBB2_HUMAN,8.13,Kd,Tclin
trazodone,ClC1=CC=CC(=C1)N1CCN(CCCN2N=C3C=CC=CN3C2=O)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.033389013,Ki,Tclin
tretinoin,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.239577517,IC50,Tchem
tretinoin,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,Nuclear receptor ROR-alpha,Nuclear hormone receptor,P35398,RORA,RORA_HUMAN,6.699999809,IC50,Tchem
tretinoin,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,6.7,EC50,Tclin
tretinoin,C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C/C(O)=O,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,6.7,EC50,Tclin
triamcinolone,C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,7.585026652,Ki,Tclin
triamcinolone acetonide,CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO,Glucocorticoid receptor,Nuclear hormone receptor,P04150,NR3C1,GCR_HUMAN,9.3,EC50,Tclin
trichlormethiazide,NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.04,Ki,Tclin
trichlormethiazide,NS(=O)(=O)C1=CC2=C(NC(NS2(=O)=O)C(Cl)Cl)C=C1Cl,Carbonic anhydrase 4,Enzyme,P22748,CA4,CAH4_HUMAN,6.35,Ki,Tclin
trifarotene,CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=C(OCCO)C=CC(=C1)C1=CC=C(C=C1)C(O)=O,Retinoic acid receptor alpha,Nuclear hormone receptor,P10276,RARA,RARA_HUMAN,6.3,EC50,Tclin
trifarotene,CC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=C(OCCO)C=CC(=C1)C1=CC=C(C=C1)C(O)=O,Retinoic acid receptor beta,Nuclear hormone receptor,P10826,RARB,RARB_HUMAN,6.9,EC50,Tclin
trifluoperazine,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,8.1,Ki,Tchem
trifluoperazine,CN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.82,Ki,Tclin
trifluperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC(=CC=C1)C(F)(F)F,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,6.78,Ki,Tchem
trifluperidol,OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C1=CC(=CC=C1)C(F)(F)F,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,9.08,Ki,Tclin
trihexyphenidyl,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.58,IC50,Tclin
trihexyphenidyl,OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,7.346787486,Ki,Tclin
triparanol,CCN(CC)CCOC1=CC=C(C=C1)C(O)(CC1=CC=C(Cl)C=C1)C1=CC=C(C)C=C1,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,Q15125,EBP,EBP_HUMAN,7.96,Ki,Tchem
triparanol,CCN(CC)CCOC1=CC=C(C=C1)C(O)(CC1=CC=C(Cl)C=C1)C1=CC=C(C)C=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,8.1,Ki,Tclin
triptorelin,CC(C)C[C@H](NC(=O)[C@@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O,Gonadotropin-releasing hormone receptor,GPCR,P30968,GNRHR,GNRHR_HUMAN,9.025,EC50,Tclin
troglitazone,CC1=C(O)C(C)=C2CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)OC2=C1C,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.013228266,IC50,Tclin
troglitazone,CC1=C(O)C(C)=C2CCC(C)(COC3=CC=C(CC4SC(=O)NC4=O)C=C3)OC2=C1C,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,P37231,PPARG,PPARG_HUMAN,6.27,EC50,Tclin
tropicamide,CCN(CC1=CC=NC=C1)C(=O)C(CO)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.522878745,Ki,Tclin
tropisetron,CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C1=CNC2=C1C=CC=C2,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,8.16,Ki,Tchem
ulipristal,CN(C)C1=CC=C(C=C1)[C@H]1C[C@@]2(C)[C@@H](CC[C@]2(OC(C)=O)C(C)=O)[C@@H]2CCC3=CC(=O)CCC3=C12,Progesterone receptor,Nuclear hormone receptor,P06401,PGR,PRGR_HUMAN,9.7,IC50,Tclin
umeclidinium,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C12CC[N+](CCOCC3=CC=CC=C3)(CC1)CC2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,10.22184849,Ki,Tclin
valbenazine,COC1=CC2=C(C=C1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2,Synaptic vesicular amine transporter,Transporter,Q05940,SLC18A2,VMAT2_HUMAN,8.522878647,Ki,Tclin
valdecoxib,CC1=C(C(=NO1)C1=CC=CC=C1)C1=CC=C(C=C1)S(N)(=O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.37,IC50,Tclin
valethamate,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)C1=CC=CC=C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,8.25,Ki,Tclin
valethamate,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)C1=CC=CC=C1,Sigma non-opioid intracellular receptor 1,Membrane receptor,Q99720,SIGMAR1,SGMR1_HUMAN,6.699999809,Ki,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Activin receptor type-1,Kinase,Q04771,ACVR1,ACVR1_HUMAN,6.82,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Bone morphogenetic protein receptor type-1B,Kinase,O00238,BMPR1B,BMR1B_HUMAN,6.62,Kd,Tbio
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Discoidin domain-containing receptor 2,Kinase,Q16832,DDR2,DDR2_HUMAN,6.49,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Ephrin type-B receptor 2,Kinase,P29323,EPHB2,EPHB2_HUMAN,6.36,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Ephrin type-B receptor 4,Kinase,P54760,EPHB4,EPHB4_HUMAN,6.28,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Fibroblast growth factor receptor 1,Kinase,P11362,FGFR1,FGFR1_HUMAN,6.25,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Fibroblast growth factor receptor 3,Kinase,P22607,FGFR3,FGFR3_HUMAN,6.62,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Mast/stem cell growth factor receptor Kit,Kinase,P10721,KIT,KIT_HUMAN,7.47,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Platelet-derived growth factor receptor beta,Kinase,P09619,PDGFRB,PGFRB_HUMAN,7.06,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Proto-oncogene tyrosine-protein kinase Src,Kinase,P12931,SRC,SRC_HUMAN,7.15,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,P07949,RET,RET_HUMAN,7.85,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Receptor tyrosine-protein kinase erbB-3,Kinase,P21860,ERBB3,ERBB3_HUMAN,6.8,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Receptor-interacting serine/threonine-protein kinase 4,Kinase,P57078,RIPK4,RIPK4_HUMAN,6.21,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Serine/threonine-protein kinase PLK4,Kinase,O00444,PLK4,PLK4_HUMAN,6.21,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Serine/threonine-protein kinase receptor R3,Kinase,P37023,ACVRL1,ACVL1_HUMAN,6.33,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Tyrosine-protein kinase ABL1,Kinase,P00519,ABL1,ABL1_HUMAN,8.05,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Tyrosine-protein kinase receptor UFO,Kinase,P30530,AXL,UFO_HUMAN,6.6,Kd,Tchem
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Vascular endothelial growth factor receptor 1,Kinase,P17948,FLT1,VGFR1_HUMAN,6.59,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.33,Kd,Tclin
vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,Vascular endothelial growth factor receptor 3,Kinase,P35916,FLT4,VGFR3_HUMAN,6.52,Kd,Tclin
vardenafil,CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,Q9HCR9,PDE11A,PDE11_HUMAN,6.89,IC50,Tchem
vardenafil,CCCC1=NC(C)=C2N1N=C(NC2=O)C1=CC(=CC=C1OCC)S(=O)(=O)N1CCN(CC)CC1,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",Enzyme,P16499,PDE6A,PDE6A_HUMAN,7.4647,IC50,Tclin
varenicline,C1[C@H]2CNC[C@@H]1C1=C2C=C2N=CC=NC2=C1,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,P36544,CHRNA7,ACHA7_HUMAN,6.9,Ki,Tchem
vemurafenib,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F,RAF proto-oncogene serine/threonine-protein kinase,Kinase,P04049,RAF1,RAF1_HUMAN,7.32,IC50,Tclin
vemurafenib,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F,Serine/threonine-protein kinase B-raf,Kinase,P15056,BRAF,BRAF_HUMAN,7.68,IC50,Tclin
vemurafenib,CCCS(=O)(=O)NC1=CC=C(F)C(C(=O)C2=CNC3=NC=C(C=C23)C2=CC=C(Cl)C=C2)=C1F,Vascular endothelial growth factor receptor 2,Kinase,P35968,KDR,VGFR2_HUMAN,6.44,IC50,Tclin
verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1,Cytochrome P450 3A4,Enzyme,P08684,CYP3A4,CP3A4_HUMAN,6.22,Ki,Tclin
vildagliptin,OC12CC3CC(C1)CC(C3)(C2)NCC(=O)N1CCC[C@H]1C#N,Dipeptidyl peptidase 9,Enzyme,Q86TI2,DPP9,DPP9_HUMAN,7.17,Ki,Tchem
viloxazine,CCOC1=CC=CC=C1OCC1CNCCO1,Sodium-dependent dopamine transporter,Transporter,Q01959,SLC6A3,SC6A3_HUMAN,6.81,Kd,Tclin
vismodegib,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1,Smoothened homolog,GPCR,Q99835,SMO,SMO_HUMAN,7.79,Ki,Tclin
vismodegib,CS(=O)(=O)C1=CC(Cl)=C(C=C1)C(=O)NC1=CC=C(Cl)C(=C1)C1=CC=CC=N1,Sonic hedgehog protein,Enzyme,Q15465,SHH,SHH_HUMAN,7.82,IC50,Tchem
vitamin A palmitate,CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,Retinol-binding protein 4,Secreted,P02753,RBP4,RET4_HUMAN,6.74,Kd,Tchem
vorinostat,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,Histone deacetylase 4,Enzyme,P56524,HDAC4,HDAC4_HUMAN,7.8,Ki,Tclin
vorinostat,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,Histone deacetylase 6,Enzyme,Q9UBN7,HDAC6,HDAC6_HUMAN,9,Ki,Tclin
vorinostat,ONC(=O)CCCCCCC(=O)NC1=CC=CC=C1,Histone deacetylase 8,Enzyme,Q9BY41,HDAC8,HDAC8_HUMAN,6.76,Ki,Tclin
vorozole,CN1N=NC2=C1C=C(C=C2)[C@@H](N1C=NC=N1)C1=CC=C(Cl)C=C1,Aromatase,Enzyme,P11511,CYP19A1,CP19A_HUMAN,8.86,IC50,Tclin
xanomeline,CCCCCCOC1=NSN=C1C1=CCCN(C)C1,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.89,Ki,Tclin
ximelagatran,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N1CC[C@H]1C(=O)NCC1=CC=C(C=C1)C(=N)NO,Prothrombin,Enzyme,P00734,F2,THRB_HUMAN,6.4318,Ki,Tclin
zafirlukast,COC1=C(CC2=CN(C)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(=C1)C(=O)NS(=O)(=O)C1=C(C)C=CC=C1,Mitogen-activated protein kinase 1,Kinase,P28482,MAPK1,MK01_HUMAN,6.269217724,IC50,Tchem
zanubrutinib,NC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1,Tyrosine-protein kinase BTK,Kinase,Q06187,BTK,BTK_HUMAN,9.52,IC50,Tclin
zofenopril,C[C@H](CSC(=O)C1=CC=CC=C1)C(=O)N1C[C@H](C[C@H]1C(O)=O)SC1=CC=CC=C1,Angiotensin-converting enzyme,Enzyme,P12821,ACE,ACE_HUMAN,9.4,IC50,Tclin
zoledronic acid,OC(CN1C=CN=C1)(P(O)(O)=O)P(O)(O)=O,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,7.21,IC50,Tclin
zolpidem,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,P14867,GABRA1,GBRA1_HUMAN,7.68,Ki,Tclin
zolpidem,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,P47869,GABRA2,GBRA2_HUMAN,6.389999866,Ki,Tclin
zolpidem,CN(C)C(=O)CC1=C(N=C2C=CC(C)=CN12)C1=CC=C(C)C=C1,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,P34903,GABRA3,GBRA3_HUMAN,6.010000229,Ki,Tclin
zonisamide,NS(=O)(=O)CC1=NOC2=CC=CC=C12,Carbonic anhydrase 2,Enzyme,P00918,CA2,CAH2_HUMAN,6.99,Ki,Tclin
zotepine,CN(C)CCOC1=CC2=C(SC3=CC=C(Cl)C=C13)C=CC=C2,Muscarinic acetylcholine receptor M3,GPCR,P20309,CHRM3,ACM3_HUMAN,7.136677265,Ki,Tclin
